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FOREWARD 
Over the last fifteen years there has been an increased emphasis on taking a 
preventative approach to reduce the risk of developing different chronic diseases 
including certain types of cancers. Between 2020 and 2030 it is expected that cancer 
will overtake cardiovascular disease as the number one cause of death in the world. The 
literature has shown that sorne types of cancers and sorne of the side effects associated 
with cancer treatment may be diminished by adopting the following recommendations: 
1) leading a physically active lifestyle; 2)maintaining a healthy weight throughoutone's 
lifetime; 3) avoiding the use oftobacco; 4) limiting the use ofalcohol. These guidelines 
have been around for the past decade and wereendorsedat the Montréal 2012 World 
Cancer Congress. 
In January 2008 a link was established with the Ville-Marie Medical Centre (VM 
Medical)where these preventative approaches could be implemented. A two-year 
process was undertaken to create an integrative health and wellness centre at VM 
Medical. Tasks included carrying out an in-housesurvey, defining the mission 
statement for the wellness center, designing the layout of the facility and finally, 
outlining the services that would be provided to patients. In the Fall of 2009 the VM 
Medical Integrative Health and Wellness Centre (WC)opened its doors; however,it 
would take another half-year before protocols would be developed and integrated with 
the medical tearn, including how the outcomes measures would be entered intothe 
electronic database.A:fter 2 Yz years of work, we were ready to begin the initial data 
collection process. The goal was to standardize the evaluation process in regards to 
body composition and blood pressure values, implement preventative protocols to 
address treatment, and advise women on healthy lifestyle choices. The importance of 
standardizing this intake evaluation and integrating it with the patient' s visit to the 
physician served to minimize the patient' s stress during the testing pro cess and 
delivered important information to the medical team. The thesis presented here includes 
a portion of the information that has been collected thus far at the WC. 
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RÉSUMÉ 
OBJECTIFS 
Cette thèse visait trois objectifs. Le premier consistait à créer un ensemble de tests 
normalisés à intégrer au processus de dépistage courant au Centre médical Ville-Marie 
(VM Médical), spécialisé dans la prévention, la détection, le diagnostic et le traitement 
du cancer du sein. Le deuxième o bje.ctif était de repérer les femmes risquant de 
développer diverses maladies cardiovasculaires et chroniques, et certains types de 
cancer. Le troisième objectif visait à déterminer quelles femmes risquent de souffrir de 
problèmes d'épaules à la suite d'une chirurgie. 
MÉTHODOLOGIE 
Les patientes de VM Médical ont été soumises à l'une des deux évaluations. Chez 
celles évaluées pendant leur bilan de santé annuel, les valeurs de la composition 
corporelle et de la pression sanguine ont été mesurées, puisqu'elles contribuent à 
déterminer le risque de maladies cardiovasculaires. Les patientes devant subir une 
chirurgie ont été soumises à un ensemble de tests sur la mobilité de l'épaule avant et 
après la chirurgie. Elles ont également reçu de l'information sur la chirurgie mammaire 
et les mesures à prendre pour minimiser les problèmes à la suite de la chirurgie. 
RÉSULTATS 
Selon l'analyse préliminaire des résultats de 9 315 patientes, les femmes ayant survécu 
à un cancer (C), qui ont été traitées contre cette maladie, étaient plus susceptibles de 
présenter des résultats défavorables concernant la circonférence de la taille, l'indice de 
masse corporelle (IMC) et la pression sanguine que les patientes régulières (R) qui 
n'ont reçu aucun traitement. Dans le groupe C, une corrélation faible a été constatée 
entre la circonférence de la taille et la pression sanguine. 
Un sous-ensemble de 1 596 patientes, regroupant 262 patientes C et 1 334 patientes 
R, a également été évalué. Dans ce sous-ensemble, les valeurs de la pression 
sanguine, de la masse grasse et de la masse maigre ont été comparées. D'importantes 
différences entre les patientes C et R ont été relevées dans la plupart des résultats. De 
plus, une forte corrélation a été établie entre les valeurs de la masse grasse et de la 
pression sanguine dans le groupe C. 
Dans un deuxième ensemble de données recueillies auprès de 4 300 patientes, une 
analyse a été réalisée pour déterminer les répercussions de la chirurgie et des 
différentes formes de traitement du cancer sur la composition corporelle et la pression 
sanguine. Les 747 femmes du groupe C ont été stratifiées selon les interventions 
chirurgicales mammaires courantes qu'elles ont subies. Les résultats de l'analyse 
indiquent que plus les interventions n'étaient invasives, plus les patientes présentaient 
des résultats défavorables. 
Ces données ont aussi été analysées en fonction des interventions thérapeutiques. 
L'analyse a démontré que les patientes ayant subi le plus de traitements présentaient les 
facteurs de risque de maladies cardiovasculaires les plus élevés, surtout parmi celles 
âgées de 40 à 49 ans. Un groupe constituait une anomalie par rapport à cette tendance : 
les femmes ayant subi une mastectomie, en particulier celles ayant subi une chirurgie 
seulement, sans aucun autre traitement. Ce groupe présentait aussi un risque accru de 
maladie cardiovasculaire comparativement aux patientes du groupe R 
Dans une autre analyse, 102 patientes ont été soumises à des tests avant et après la 
chirurgie. Selon les résultats des tests pré-chirurgicaux, un nombre élevé de femmes 
présentaient un conflit sous-acromial et un syndrome de la traversée thoraco brachiale. 
Les résultats des tests post-chirurgicaux ont démontré une diminution de la flexion de 
l'épaule, dont l'importance dépendait du type de chirurgie. La perte était supérieure 
chez les patientes ayant subi une mastectomie complète comparativement à celles ayant 
subi une mastectomie partielle. 
CONCLUSION 
Les femmes ayant reçu un traitement contre le cancer affichaient des valeurs 
défavorables par rapport aux autres en ce qui concerne la composition corporelle et la 
pression sanguine, et courraient donc un risque plus élevé de maladies 
cardiovasculaires. Il convient de souligner que ce risque accru était peut-être présent 
avant le traitement ou peut avoir été exacerbé par le traitement. 
Le traitement vise principalement à atténuer les conséquences du cancer. 
Malheureusement, il peut entraîner certains problèmes secondaires, par exemple un 
risque accru de maladies cardiovasculaires et métaboliques. Comprendre ces risques 
contribuera à améliorer la qualité de vie des personnes survivant au cancer. 
Mots-clés: cancer du sein, pression sanguine, composition corporelle, conflit sous-
acromial 
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ABSTRACT 
OBJECTIVES 
The objectives of this thesis were three-fold. The fust objective was to establish a series 
of standardized testing proceduresto be included in the regular screening process at the 
Ville-Marie Medical Centre (VM Medical), a centre that specializes in the prevention, 
detection, diagnosis and treatment ofbreast cancer. The second objective was to identify 
women who may beat risk for various cardiovascular and chronic diseases, as well as at 
risk of developing certain types of cancers. The third objective was to identify women 
who may beat risk for shoulder problems associated with a surgical intervention. 
METHODOLOGY 
Patients at VM Medical underwent one of two different evaluations. Patients who 
were being evaluated as part of their annual medical examination, had body 
composition and blood pressure values measured to help assess their level of risk for 
cardiovascular disease. Patients who were scheduled for surgery, underwent a series 
of pre- and post-surgery shoulder mobility tests,and were also provided with 
information on what to expect with breast surgery and what to do to minimize post-
surgical problems. 
RESULTS 
Preliminary analysis of 9,315female patients found that cancer survivors (CS), who 
received cancer treatment, were more likely to have poorer outcome measures related 
to waist circumference, body mass index (BMI) and blood pressure compared to 
regular (R) patients who had not received any treatment. A weak correlation was 
found between waist circumference and blood pressure in the CS group. 
A subset group of 1,596 patients made up of262 CS and 1,334 R patients were also 
evaluated. In this analysis, blood pressure, body fat and lean muscle mass were 
compared. Significant differences were observed between CS and R patients inmost 
measurements and a good correlation was seen between body fat and blood pressure 
values in the CS group. 
In a second set of data collected on 4,300 patients, an analysis was conducted to 
determine how surgery and different forms of cancer treatment affected body 
composition and blood pressure values.The 747 women in the CS group were 
stratified according to common surgical interventions for breast surgery. The analysis 
showed that the more invasive the intervention the women received,the poorer were 
the outcome measures. 
The same data was analyzed based on treatment intervention. The more treatment the 
patient received, the greater the impact was on cardiovascular risk factorsespecially,in 
the 40-49 age group. The one group that was an anornaly from this trend was the 
mastectomy group, in particularthose who had surgery alone and no other treatment. 
This group also exhibited increased risk of cardiovascular diseasecompared to the R 
patients group. 
xv 
In another analysis, 102 patients were tested before and a:fter surgery. Pre-surgery 
testing demonstrated that a significant number of the women had positive tests for 
shoulder impingement and thoracic outlet problems. Post-surgery testing showed a 
decrease in shoulder flexion, the significance of which,depended on the type of 
surgery performed. Patients that underwent a full mastectomy were affected more 
severely than patients who underwent a partial mastectomy. 
CONCLUSION 
Women who received cancer treatment displayed poor body composition and blood 
pressure values,creating a riskfor cardiovascular disease. Note that this risk may have 
been present before treatment and/or exacerbated by treatment. 
The primary goal oftreatment is to address the underlying problems associated with 
cancer. Unfortunately, treatment can lead to sorne secondary problems such as 
increased risk for cardiovascular disease as well as metabolic diseases. Understanding 
these risks could help improve the quality of life for cancer survivors. 
Keywords: Breast cancer, blood pressure, body composition, shoulder impingement 
CHAPTERI 
INTRODUCTION- REVIEW OF THE CURRENT LITERA TURE 
1.1 Breast Cancer 
Over the past 15 years there has been a growing body of evidence to indicate that 
people who are diagnosed with cancer should utilize exercise to diminish the negative 
effects of cancer therapy (Kruijsen-Jaarsma et al. , 2013). The idea of exercise having a 
positive impact on someone's life has even gone one step further. Major health 
organizations have started to take the position that people can reduce their risk of 
developing certain types ofillnesses and cancers if they include exercise as part oftheir 
daily activities (World Cancer Research Fund, 2007). These same health organizations 
have also indicated that once someone has had cancer and undergone adjuvant therapy, 
they should include regular physical activity as a way to reduce their risk ofthe cancer 
re-occurring (World Cancer Congress, 2012). 
There are over 200 different types of cancers (MacDonald, Ford and Casson, 
2004).This research project focused on one type of cancer, that is, breast cancer.Breast 
cancer is the most common cancer affecting women around the world, accounting for 
23% of ali cancers worldwide. According to Statistics Canada, it is estimated there will 
be approximately 22,800 new cases and 5, 000 deaths from this disease in Canadain 
2013 (Canadian Cancer Society/Statistics Canada, 2013).Breast cancer in Canada 
accounts for 26% of ali women's cancers. About 1 in 9 women will develop breast 
cancer in their life time. Due to advances in prevention, early detection and treatment, 
however, the number of women surviving breast cancer has increased drarnatically in 
recent years. 
Epidemiologie studies have linked obesity and low levels of physical activity with an 
increased risk ofbreast cancer (Brown et al. , 2003; Thune and Furberg, 2001). Clinical 
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and epidemiologie studies have also identified obesity and weight gain as important 
negative prognostic factors for survival among women with this disease (Chleboski, et 
al., 2002). Physical activity has been associated with weight loss and weight 
maintenance among healthy individuals (Irwin et al., 2004; Wing, 1999). Studies have 
shown a favourable effect of exercise on body weight among breast cancer survivors 
(Rock and Demark-Wahnefried, 2002; Irvin et al., 2004). Despite the evidence 
indicating that regular physical activity can protect against weight gain, decrease breast 
cancer risk, and potentially improve breast cancer prognosis, efforts to encourage 
physical activity are not a routine part of the cancer treatment or rehabilitation process. 
Rarely are the topics of exercise and levels of activity addressed or even considered 
when patients are consulting with their physicians. The evidence is conclusive that 
physical activity for women before, during and after breast cancer therapy has a 
positive influence on the women's overall health. Physical activity intervention 
researchers have been faced with similar challenges when evaluating activity levels and 
developing effective strategies aimed at physical activity behaviour 01 allance et al., 
2007). Unfortunately despite the reported benefits of physical activity, the majority of 
breast cancer survivors are not meeting public health guidelines (at least 150 min/wk. 
ofmoderate-to-vigorous intense physical activity) (Irvin et al., 2004). This difficulty to 
modify breast cancer survivors' physical activity behaviour seems to extend to the 
general population. 
Several questions need to be asked: 1) Are women interested in finding out about 
exercise? 2) Are women utilizing the available resources to learn about exercise? 3) 
Are women actually changing their activity habits? 4) Are these changes in physical 
activity habits being reflected in women's body compositions and levels offitness? 
The fust question was addressed in a preliminary survey that was performed at VM 
Medical in 2007. The survey was performed to gain a better understanding of the 
interest patients of the clinic would have in receiving information and guidance on 
.----- ------ -----------------------------
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exercise (Jones et al., 2008). The in-house survey helped to evaluate the interest in 
establishing an onsite fitness center for the women at VM Medical. Over a one-month 
period, 606 women atthe clinic were asked about their level of activity, their interest in 
receiving direction on exercise and exercise rehabilitation, and whether they would 
make use of a local facility to exercise (Jones et al., 2008). The survey indicated that 
45.4% (276) of the women considered thernselves regular exercisers, 43% (263) of the 
women would be interested in receiving individual instruction on exercise and 34% 
(203) of the women would like the · service to be available at VM Medical. 
The results of the survey led to the opening of a fitness centre at VM Medical in 
November 2008. This led to the following questions: Has the establishment of a fitness 
program at VM Medical had an impact on the fitness level and body composition of the 
clientele? Is there a difference in cardiovascular risk factors between women who have 
been treated for breast cancer and women who are part of the regular patient clientele? 
1.2 Shoulder problems associated with treatment for breast cancer 
A number of studies have looked at the impact exercise has on people undergoing 
cancer therapy (I)ruijsen-Jaarsma et al. , 2013). Sorne studies have evaluated women 
before and after chemotherapy. However, many studies are done in a post hoc manner, 
often after the completion of adjuvant therapy. The physical condition of the women 
before any type of exercise 1 physical activity interventions has gone relatively 
unstudied. For example, it is unclear how many women present with underlying 
shoulder pathology since current fitness levels and physical activity histories are 
seldom reported. When these measures are obtained, it is often after the initial 
intervention of cancer treatment; many times the measures are never taken. This is wh y 
it has been recommended that screening for pain and range of motion (ROM) 
restrictions has become an integral part of breast cancer follow-up care (Thomas-
Maclean et al. , 2008). 
4 
Aside from the lack of physical activity, survivors of breast cancer must deal with a 
host of physical, psychological and sociological problems that can occur with 
treatment. At this point it is appropriate to review sorne of the expected challenges 
women may encounter while undergoing therapy. 
Breast cancer therapy may cause unfavourable changes in physical functioning, body 
composition, psychosocial functioning, and quality of life (QOL) (Courneya et al., 
2007). Sorne ofthe limitations may include: 1) Weight gain, a commonly reported side 
effect of adjuvant chemotherapy (Campbell et al. , 2007); 2) Breastcancer-related 
lymphoedema (BCRL) -- a chronic swelling that can occur in the ipsilateral hand or 
arm ofwomen treated for breast cancer (Lane et al. , 2005); 3) Pain and ROM (Thomas-
Maclean et al. , 2008); 4) Overall body fatigue during and after treatrnent (Dimeo et al. , 
2008); and 5) Decrease in physical activity level leading to changes in body 
composition that may have important health implications for survivors (Campbell et al. , 
2007). 
It is clear that the need to regain shoulder mobility exists for this cohort of women, to 
avoid prolonged shoulder problems. One approach that maybe utilized to address this 
problem is to control the amount ofpostoperative pain the women are enduring so that 
they may begin to move their arm. Research projects by different groups (Kilgour et 
al. , 2007) try to minimize the amount of post-operative shoulder dysfunction that does 
take place through the use of a home-based exercise program, but there is still much 
work to be do ne. 
Certainly having a portion of one' s body removed is a very traumatic event but in 
comparison to many types of orthopedie surgery in and around the shoulder, this 
intervention is considered minor surgery (Leidenius et al. , 2003). Oncology physicians 
are still not certain why so many women run into problems, yet many of the women 
who do undergo this regime of treatment are at risk for developing chronic arm, 
shoulder and neck problems (Leidenius et al., 2003). 
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Delay in, or lack of, immediate postoperative exercise may result in adverse outcomes 
such as spasm of the musculature surrounding the joint, muscle atrophy, tightening of 
the shoulder capsule and decreased short-and long-term functional mobility, leading to 
chronic immobility and pain (Kilgour et al., 2008). 
Concerning shoulder function, two comparative studies have described significantly 
less impaired function after Breast Cancer Therapy (BCT) compared to ROM and 
moderately impaired shoulder mobility reported after BCT. Other studies have found 
no significant differences in such impairment between patients treated for BCT or 
ROM (Emst et al. , 2002; Kuehn et al., 2000). 
It is possible that women may be predisposed to developing problerns in the upper 
body. Thus, it may also be important to look at other areas of daily living where women 
may be at risk for developing pain in the neck, shoulder and arm regions. These 
predispositions to developing upper body complications are outlined in the following 
section. 
Women who have a pre-existing shoulder pro blem: 
A number of studies have shown that workers, performing the same movements over 
prolonged periods of time, are prone to be at risk of developing chronic 
musculoskeletal dysfunction and possibly neurological problerns. These workers fall 
into a number of occupational groups, from manuallabourers, workers in jobs that are 
considered hazardous( e.g. forestry), assembly line workers, professional support staff, 
and office workers, to name a few. In this project we focused on office workers whose 
jobs require them to spend a good portion oftheir workday at computer terminais. Over 
time this group demonstrated that they were at risk of developing problerns in the neck, 
shoulder and arm regions (Johansson et al. , 2003; Luime et al., 2004). These problerns 
may include pain in the neck due to muscle tension, possibly leading to tension 
headaches. The pain in the shoulder region may be due to tendonitis (Lundberg et al. , 
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1999), possible nerve entrapment, causing periodic numbness (Pascarelli and Hsu, 
2001), thoracic outlet, or brachial plexopathies (Mense and Simons, 2001). The pain in 
the elbow/forearm region may be related to lateral or medial epicondylitis (Johansson 
et al., 2003). Finally pain in the wrist, hand and :finger may be due to carpal tunnel 
syndrome and/or Dequarvian syndrome (Rice et al., 1996). 
A common thread among workers who experience pain in the neck, upper torso and 
arm regions, is that they are often asked to perform a task(s) that requires a muscle or 
group of muscles to maintain a static position for a prolonged period of time (Mense 
and Simons, 2001). This may be somewhat contrary to what many people may think 
leads to an increase in the risk of problerns. The general population may believe that 
only workers who perform tasks that involve large muscle groups, like manual 
labourers, would be at risk. This perception has led to a delay in understanding and 
appreciating the impact oflow intensity and repetitive movement have on the worker 's 
body (Mense and Simons, 2001). 
Women seem to be at greater risk for developing pain in the neck, shoulder and arm 
regions in comparison to men (Chesterton et al. , 2003). Women often comprise a 
significant portion of different occupations (Sorock and Courtney, 1996) that are most 
at risk to upper body injuries. Men have also been shawn to have repetitive injury 
syndrome, but not to the same extent as women. When evaluating the work of men and 
women who work on production tines, there is a similarity in the type of chronic 
injuries that occur (Westgaard and Winkel, 1996), although women seem to be a:ffected 
to a greater extent. There is growing consensus that musculoskeletal disorders may be 
related to the occupational activities of the individuals (Punnett and Wegman, 2004) 
but it is still unclear how much predisposing factors play a role in a worker developing 
musculoskeletal disorders. A common trend that is seen in many of these studies is the 
high prevalence of neck-shoulder pain in females (Chesterton et al. , 2003). 
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An evaluation of muscle fiber composition in the trapezius muscle of the neck and 
shoulder region, showed a significant difference between men and women (Lindman et 
al; 1990, and 1991). This study led to speculation that women maybe at greater risk for 
developing neck, shoulder and arm problems. Through the use of muscle biopsies, a 
significantly greater proportion of type 1 muscle fibers were found in the trapezius 
muscle ofwomen in comparison to men (Lindman et al., 1990; 1991). Thus, having a 
greater composition of type 1 (slow twitch fatigue resistant) fibers in the trapezius 
muscle would perhaps allow a worker not to fatigue as quickly when performing low 
intensity tasks, in comparison to type 2 fibers . On the other hand, having a greater 
composition of type 2 fibers (fast twitch non-resistant to fatigue) in the trapezius 
muscle, a worker would be able to generate greater explosive contractions/force, but 
would fatigue quicker. This initial investigation led Lindeman et al., (1991) to evaluate 
the way women and men perform the same activity, specifically data entry. The women 
involved in the study were shown to use shoulder, armand wrist motions in a different 
manner compared to men and were expending significantly more energy. The women 
were also often found to be much more effective at entering large volumes of data 
compared to men. Entering more data and expending more energy may also be two 
factors that have contributed to women experiencing more pain while performing this 
task in comparison to men, who used less energy as well as entered less data (Lindman, 
Eriksson andThomell, 1990). 
Karlqvist et al. (2003) believe that workers that are in poor physical condition are at 
greater risk for developing pain and dysfunction in different regions of the body. Their 
work has shown that workers, both men and women, but in particular women, are not 
in good physical condition and that the jobs they perform on a regular basis do not 
irnprove their fitness level. If anything, the jobs tend to be deleterious to workers' 
health (Chesterton et al., 2003). 
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It has been shown that many women are at risk of developing musculoskeletal pain in 
the upper body particularly the neck and shoulder regions. Often the jobs that they 
perform along with the muscle fiber composition in their neck and shoulder region 
place them at greater risk of developing pain in these two locations compared to men 
(Chesterton et al., 2003; Johansson et al., 2003). 
It would be expected that any pain a woman experiences in the neck and shoulder 
regions would have a lower priority once a lump in the breast has been discovered and 
surgery is recommended. It is unclear how many women who begin adjuvant therapy 
are dealing with musculoskeletal restrictions in these areas. Thus the above discussion 
leads to the following question:Does the presence of pre-existing upper body 
dysfunction prolong the recovery time for women who are undergoing breast sparing 
surgery? 
Research has indicated that women who work outside of the home appear to be at 
greater risk of developing orthopaedic problerns in the neck, shoulder and arrns. 
Furthermore, women in western society also appear to be at greater risk for developing 
breast cancer compared to their eastern counterparts. The goal of this project is to 
evaluate the possible 1ink between breast cancer therapy and the risk of developing 
upper body dysfunction in women who are undergoing adjuvant therapy. We believe 
that a number of women may already be at risk for developing problems in the upper 
body and that breast cancer therapy :further increases their risk of dysfunction. 
Understanding the risk and implementing preventative strategies may help these 
women better tolerate the treatment protocols. 
It seerns apparent from the above ·discussion that the need to regain shoulder mobility 
exists for this cohort of women in order to avoid prolonged shoulder problerns. One 
approach that may be utilized to address this problem is to control the amount of 
postoperative pain the women are enduring so that they may begin to move the afflicted 
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ipsilateral arm. Exercise is a popular method to address limited shoulder and arm ROM 
(Kilgour et al., 2007). 
1.3 Summary oflntroduction 
Consistent with the requirements of a doctoral thesis, thiswas amulti-staged 
projectmade up of the following five stages; 
Stage 1 
In stage 1 of the project, I began with areview of the patient file database at VM 
Medical. The initial objective was to determine the cardiovascular risk of the women at 
the Centre, which led to evaluating the possibility of implementingstandardize 
procedures for obtainingthe anthropometrie measurements, and blood pressure and 
resting heart rate values of the women. Also, testing of cancer survivors (CS) and 
regular (R) patientswas done to see whether there were any differences between the two 
groups. We noteda relationship between blood pressure and waist circumference in 
both of the groups. 
Stage 2 
In stage 2 of the project, weinvestigated the use of bioimpedence to measure body 
compositionin CS andR patients. The additional information provided from 
bioimpedance allowed us the opportunity to evaluate the relationship between body fat 
and blood pressure. 
Stage 3 
In stage 3 of the project we utilized the standardized measurementsof stage 1 and took 
into consideration the type of surgery and treatment that the women underwent. We 
then stratified the women according to the type of surgery and treatment they received. 
Stage 4 
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In stage 4of the project we looked at the incidence of pre-existing shoulder dysfunction 
and shoulder range of motion ROM in women preparing for breast surgery. 
Stage 5 
In stage 5of the project we implementedthe Jones template (Jones et al, 2007) to 
evaluate women who were about to undergo surgery associated with breast cancer. The 
template evaluation was included in the regularpre-surgery and post-surgery evaluation 
process. At this stage the evaluator used the Jones template along with orthopaedic 
testing to evaluate if thewomen presented withupper body problems in addition to a 
diagnosis of a suspicious breast rnass. The expectation was that the women who already 
had pro blems in the upper body be fore surgery were much more likely to continue to 
have problerns after surgery. 
1.4 Hypotheses 
The working hypothesis was that cardiovascular risk factors were related to deleterious 
changes in body compositioiL The specifie hypothesis for each stage of the project are 
as follows; 
Stage 1 
The hypothesis for this stage was that anthropometrie measurements are directly 
proportional to deleterious cardiovascular risk factors. 
Stage 2 
For stage 2 the hypothesis was that an increase in resolution of body composition 
provided by bioimpedance analysis discriminates cardiovascular risk factors between 
cancer survivors (CS) and regular (R)patients. 
Stage 3 
,-----------------------
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The hypothesis for stage 3 was that cancer surgery and treatment type has a negative 
effect on both body composition and cardiovascular risk factors in CS when compared 
to R patients. 
Stage 4 
In this stage the hypothesis was two-fold. First, we expected that a number of women 
would be at risk for developing shoulder problems before breast surgery.Secondly, 
wesuspected that sorne of the women were not meeting recommended fitness 
standardsand that there would be a difference between CS and R patients. 
Stage 5 
We expected that certain locations on the Jones template would be more sensitive than 
other locations for breast cancer patients. 
CHAPTERII 
METHODOLOGY 
2.1 Primary screening of VM Medical patient data base 
2.2 Stage l:Preliminary evaluation 
AB part of the standard intake evaluation, patients waiting to meet with one of the 
physicians at the WC underwent a series of tests administered by one of 
theCentre' skinesiologists. Results from tests, which included vital signs and body 
composition measurements, were entered into VM Medical'selectronic medical 
records. Each patient that came to VM Medical was asked to review and consider 
signing a consent form that allowed for their medical information to be entered into the 
electronic database. The information that was extracted from the electronic database 
and which was used for this study, was stripped of personal information so that no 
individual could be identi:fied. The electronic database was used by the medical team 
to monitor and address patient needs. This study was approved by VM Medical Ethics 
Board and conforrned to the World Medical Association (WMA) Declaration of 
Helsink~ Ethical Principles for Medical Research Involving Hurnan Subjects. 
AB part of the preparation for testing, patients were asked to refrain from smoking or 
drinking caffeine products for at least 4 hours prior to testing.Before testingbegan, 
patients were also asked if they needed to use the washroom to void any fluids. Testing 
of the patient took place in a medical evaluation room, away from the main clinic area. 
The kinesiologist explained to the patient the purpose for the testing. After 
approxirnately 5 minutes the patient was then given the opportunity to relax and ask 
questions before the testing began. 
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Resting heart rate and blood pressure values were obtained through the use of an 
automated sphynomanometer(Physiologic Auto-memory 90; AMG Medical Inc., 
Montréal Canada). The patient's left arm was used for testing. If the patient had breast 
surgery on the le:ft side oftheir torso with lymph node(s) removed, the right arm was 
used. 
The cu:ffwas wrapped around the upper armand was supported at the level of the heart. 
The cuffwas aligned with the brachial artery. Ifmeasurements obtained on the patient 
were outside of expected values for the patient's age group, the test was repeated after a 
5-minute waiting period. 
The patient' s height was taken using a stadiometer ( equipment used for measuring 
height, consisting of a vertical ruler with a sliding horizontal rod that is adjusted so that 
it rests on the top of the head.Also, the patient's weight was taken using a weight scale. 
Waist circumference was the last measurement taken.The American College of Sports 
Medicine (ACSM) 2013, guidelines were followed to measure waist circumference and 
was measured at the level of the greater trochanter of the hip and the umbilicus using a 
Gulick anthropometrie tape (Mississagua, Ontario Canada). Waist measurements were 
taken with the patient standing upright, feet together, and arms at their side while 
maintaining a relaxed breathing pattern. A horizontal measure was taken at the 
narrowest location between the umbilicus and the sternum. The test was repeated twice 
and the average was taken. If there was a difference of more than 5 millimeters 
between measurements, a third measurement was taken. 
Patients were classi:fied into two groups;cancer survivors (CS) or regular (R) patients. 
All of the women classified as CS underwent either a partial or a full mastectomy and 
may also have received adjuvant therapy such as chemotherapy, radiotherapy and 
hormonal therapy. Sorne patients may have received only one adjuvant therapy while 
others may have received up to three. Patients classi:fied, as R patients may not have 
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had any of the adjuvant therapies mentioned above. Both the CS and the R patients may 
also have had other health issues for which they were taking additional medication that 
may have affected outcome measurements. 
2.3 Stage 2: Inclusion of the bioimpedance unit to measure body fat 
The recently validated (Karelis et al 2013) body composition measurement by 
bioimpedance was used to determine body weight, percent body fat, lean muscle mass, 
and total body water. Before standing on the foot pads of the unit (In-Body 230; Seoul, 
Korea), the patient was asked to remove her shoes and socks as weil as any external 
metal objects (e.g. watches, rings) that might affect the results. The patient was asked to 
hold on to the external handles of the unit allowing data to be collected and 
documented from the display by the kinesiologist. 
2.4 Stage 3: Stratifying by surgery and stratifying by treatment 
CS were strati:fied according to one of five common surgical interventions that they 
underwent: 1) A partial mastectomy; 2) A full mastectomy; 3) Bilateral surgery; 4) 
Bilateral full mastectomy; and 5) Reconstruction, either a unilateral reconstruction or 
bilateral reconstruction that may have occurred on the same day as the full mastectomy 
or on a different day. 
CS were also strati:fied according to the treatment intervention they underwent. The 
eight different categories included: 1) Surgery only; 2) Surgery and chemotherapy; 3) 
Surgery and radiotherapy; 4) Surgery and hormone therapy; 5) Surgery, 
chemotherapy, radiotherapy and hormone therapy; 6) Surgery, radiotherapy and 
hormone therapy; 7) Surgery, chemotherapy and radiotherapy; and 8) Surgery, 
chemotherapy and hormone therapy. 
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2.5 Stage4: Pre-surgery shoulder assessment 
Patients who were scheduled for breast surgery were asked to undergo a preoperative 
evaluation by the kinesiology team. The preoperative session had five main 
components that included; 1) Outlining to the patient what she could expect 
postoperatively; 2) Reiterating the surgeon's preoperative instructions; 3) Outlining the 
post-operative exercises that needed to be performed; 4) Performing base line testing of 
patients -including shoulder mobility, arm strength, present activity level, body 
composition, shoulder impingement and testing to evaluate neurovascular occlusion; 5) 
Addressing additional questions that the patient had concerning treatment. 
Kinesiologists met with each patient for approximately 90 minutes. Recognizing the 
amount of stress that the patient was under and given the recent diagnosis of a 
suspicious lump in their breast, it was left to the discretion of the kinesiologist working 
in consultation with the patient to determine what information and testing was most 
important for the patient at that particular stage. 
A series of tests were performed to evaluate the patient's shoulderrange of motion 
(ROM), forearm strength, and the presence of shoulder pain or reduced upper extremity 
circulation before surgery. The breast surgery performed was either a partial or full 
mastectomy with sentinel node or axillary node sampling. 
Before their surgery the women were asked to undergo testing (methodology described 
below) to evaluate their current level of shoulder ROM and their current level of 
physical activity. During the testing session, the kinesiologists advised the women on 
the appropriate exercises to . be performed postoperatively. Also, the womenwere 
provided an opportunity to clarify any questions they had concerning potential 
postoperative problems. Again, recognizing the amount of stress that the patient was 
under with a recent diagnosis of a suspicious lump in their breast, it was left to the 
discretion of the kinesiologists working in consultation with the patient to 
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determinewhat information and testing was most important for the patient at this stage. 
The following tests were performed; 
Shoulder Flexion 
Shoulder flexion was assessed with the use of a handheld goniometer, an instrument 
used to measure range of motion (ROM). The subject was assessed in a standing 
position, with the axis of the goniometer positioned at the acromion process of the 
scapula, through the head of the humerus. The stationary arm of the goniometer was 
placed along the mid axillary line of the trunk, while the moving arm was placed along 
the midline ofthe humerus in line with the lateral epicondyle. 
Forearm Strength 
A Jamar handgrip dynamometer (Lafayette Instruments, Lafayette, IN USA) was used 
to assess forearm strength. The adjustable handle was fit to the hand size of the patient 
so that the proximal interphalangeal (PIP) joints of digits 2 through 5 were positioned 
at a 90degree angle of finger flexion as a starting position. The subject kept their 
shoulder in a neutral position and their elbow extended by their side while performing 
the test. The subject squeezed the dynamometer with maximum isometric effort, and 
maintained the effort for 5 seconds. 
Shoulder Dysfunction 
Shoulder irnpingement was assessed with the use of the Neer test and the Hawkins 
Kennedy. With the Neer test, the patient's arm was moved into end range of flexion at 
the same tirne as the patient's scapula was stabilized. The test was considered positive 
if it elicited pain, typically at the end of the range of flexion. If the patient had full 
shoulder flexion with overpressure applied at the end of the range without experiencing 
pain, then the test was considered negative. 
The Hawkins Kennedy test0 was performed by flexing the elbow to 90 degrees and 
then elevating the patient's arm to 90 degrees of shoulder flexion and then intemally 
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rotating the shoulder. The patient either experienced pain with this manoeuvre or tried 
to elevate the ipsilateral shoulder to increase the subacromial space and prevent the 
impingement. 
When pain occurred with either of these tests, it was considered a positive sign for 
sub-acromial impingement. The goal behind these tests was to transiently aggravate 
inflamed or impinged structures as they passed under the coracoacromial arch. The 
inflamed structures may have included the long head of biceps tendon, the 
supraspinatus tendon and/or sub acromial bursa. 
Thoracic outlet test using the Roos test 
Testing was performed to assess for the possibility of neurovascular occlusion o:ften 
associated with thoracic outlet syndrome through the use of a Roos Test (Howard, Lee 
and Dell 2003).The patients were asked to abduct both shoulders to 90 degrees and 
then flex both oftheir elbows to 90 degrees. Patients were then asked to open and close 
their hands repeatedly for up to 3 minutes. During that tirne if the patient started to 
experience numbness and/or a pins and needles sensation in the hands, the test was 
stopped and a positive sign noted. lfthere was no presence ofnumbness and/or a pins 
and needles sensation, then a negative sign was recorded. 
Lev el of activity 
To gain an understanding of the patient' s typical level of physical activity, patients 
were asked to indicate what best represented their current level of activity. The scale 
was: 1) Active, 1 day per week; 2) Active 3-5,days a week; and3)Active, every day of 
the week. 
Patient' s height and weight were recorded and classified according to BMI (Body Mass 
Index) based on guidelines from the Canadian Physical Activity, Fitness and Lifestyle 
Approach (CP AFLA, CSEP, 2003). Patients were ranked as follows; Mild Thinness 
(BMI ofless than 17.9); Normal (BMI 18.0-24.9), Overweight (BMI 25 .0-29.9), Obese 
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levell (BMI 30.0-34.9), Obese level2 (BMI 35.0-39.9), Obese level3- morbidly obese 
(BMI greater than 40.0). 
Data analysis 
Statistical analysis was performed using IBM SPSS versionl9.0. A one-way nova with 
Tukey post-hoc analysis was performed on shoulder ROM measures with significance 
assumed at P<0.05. Simple t-tests were performed on handgrip strength measures. 
Significance was set at P< 0.05. Pearson correlation was used to evaluate relationships 
between outcomes measures. Signifi.cance was set at P< 0.05. 
2.6. Stage S:Evaluation of the fitness level of patients 
An evaluation of the fi.tness level of patients was performed on both R patients and CS 
at the WC. A battery of tests,proposed by the CanadianSociety of 
ExercisePhysiology,namely the Canadian Physical Activity Fitness & Lifestyle 
Approach (CPAFLA, CSEP 2003), was utilized to evaluate the patients. The tests are 
based on age-matched data to determine how each individual rank:ed in comparison to 
people in the same age-matched group. The tests included assessment of low back and 
abdominal strength, hand grip strength, lower body flexibility as well as aerobic testing 
with the use of a treadmill and the modifi.ed Bruce protocol. A screening process was 
done to identify women that were at risk, either a Physical Activity Readiness -
Questionnaire (ParQ) or a medical ParQ form was completed for each patient that was 
tested. 
2. 7 Stage 6: Validation of the Jones template on breast cancer patients 
In this stage the subjects underwent primary and secondary measures that are outlined 
in the following protocol. 
Pre and post surgical measurements in both Stage 4 objective measures and self-
reported data were collected. The outcome measures were repeated for both stages. 
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Primary outcome measures were: 1) The assessment of arrn!shoulder mo bility using 
the "arm-shoulder/upper torso grid" developed by Jones et al. (2007) to measure 
pressure pain threshold (PPT) with a handheld algometer. The upper body grid 
evaluates the PPT of eight different locations in the upper armand torso. The specifie 
locations were selected for the following reasons; 1)Several of the locations such as 
the trapezius, deltoid and infraspinatus have been used in previous studies. 2) 
Locations such as the rhomboid and supraspinatus have often been identified in a 
clinical setting as being problematic. 3) The biceps and triceps were selected because 
these regions have been found to be frequently painful especially in women who have 
had breast surgery with an axillary node dissection for the determination of breast 
cancer. Sensitivity of locations and possible trigger points were noted and recorded. 
This template is important when considering the fact that many breast cancer patients 
develop myofascial dysfunction characterized by the presence of palpable nodules 
"trigger points" (Cheville 2007). (Evaluation time required, 25 minutes) 
Twenty one (21) female subjects were recruited from VM Medical. Demographie 
information including age, height, weight and mean body mass was collected. 
As part of their job, subjects typically spent at least 2 hours a day at a computer 
terminal. Sorne subjects experienced shoulder pain or significant musculoskeletal 
pain at the time but were not receiving any therapeutic treatments to address their 
exisiting problems. Subjects were recruited for this study following approval of the 
l'Université du Québec à Montréal (UQAM) Human Research Ethics Committee. 
Each subject had ail of the risks of participating in this study explained to them and 
were asked to voluntarily give their written informed consent. (Annexes 1 &2) 
The subjects were asked not to undertake any new physical activity in the two days 
preceding the testing. New physical activities were de:fined as activities performed 
routinely for an extended period of time (for example, weight training after a 
prolonged period of inactivity). The ingestion of caffeine has been found to alter a 
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person's perception of pain so subjects were asked to avoid ingesting any caffeine 
products (Galeotti et al., 2002) for at least 4 hours prior to each testing period. 
Subjects werealso asked to avoid any analgesie medication for 12 hours prior to the 
testing time. 
Women participating in this project underwent repeated measures at 3 different 
intervals during a 2-month period beginning from the timeof theirbreast cancer 
diagnosis. The objective measures were repeated (Maastricht questionnaires were 
only completed at the pre-surgery evaluation). 
All participants for this project were recruited through VM Medical. The women in 
the project,aged 25-60, were in relatively good health, and without multiple health 
related problems with the exception of being diagnosed with a suspicious breast 
mass. The attending physicianl medical team recommended a course of treatment 
which either began with surgery or neo-adjuvant therapy. The women participating in 
the project did not have any psychological or emotional factors which would have 
limited their ability to understand the project. The women werethen referred to the 
VM Medical Intergrative Health and Wellness Centre(WC) where baseline 
measurements were taken. 
As with most research we wanted to have a positive impact on the lives of the women 
dealing with breast cancer. Our goal was not to establish a program that would end 
when the research project ended. Our goal was to irnplement changes in the typical 
protocols for breast cancer patients so as to diminish the negative signs and 
symptoms associated with treatment. A number of the tests that were used in this 
proto col could easilybe carried over to clinical situations, and utilized as part of the 
standard protocol/procedure for patients. 
Materials 
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The testing protocol outlined in detail below was initially utilized and validated in the 
2008 Masters project by D.H. Jones. For consistency the same calibration of the 
algometer, subject preparation, testing locations on the subject, and application of the 
algometer, were utilized for all projects. 
Algometercalibration and application: 
Calibration: 
The algometer was calibrated at the ons et of each day of testing before being applied 
to the subject. The algometer (Somedic Algometer Type II;Somedic Production AB, 
Sollentuna, Sweden) was calibrated using a standard protocolrecommended by the 
manufacturer. The acceptable calibration values ranged from 98 to 102 kilo pascals. 
This meant a potential 4% error in the recorded values. The calibration process was 
repeated 3 times to mak:e sure that calibration values fell within the ex:pected range. 
When the values did not fall within the acceptable, ± 2 kilopascal range, the 
algometer was restarted and the calibration process repeated. 
Application: 
Following the manufacturer' s calibration guidelines, the 0.5cm applicator head was 
replaced with a 2cm applicator head to measure PPT's. The 2 cm applicator head 
reduced the risk of causing excessive pain, and bruising.Using anapplicator head 
smaller than 2 cm on subjects who werepost-surgery may have placed them at an 
increased risk of bruising and localized tissue trauma. This may have heightened their 
concern about developing lymphedema, a significant problem for this population 
(McCredie et al. , 2001). The 2 cm applicator appears to have been more effective at 
indicating local pain sensation when compared to smaller applicator heads (Takahashi 
et al., 2005). 
Patient Position 
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The subject was placed in a supine position on a portable treatment table and then in a 
prone position on the same table. The two different positions were used so that the 
algometer could be safely applied and allowed for better stabilization of shoulder and 
torso compared to a seated position. With the subject in the supine position, the 
kinesiologist applied the algometer to the anterior aspect of the shoulder and arm for 
the PPT measurement over the marks located on the anterior deltoid and bicep. With 
the subject in a prone position, thekinesiologist then applied the algometer to the 
posterior aspect of the arm (triceps), shoulder (posterior deltoid) and torso 
(in:fraspinatus, supraspinatus, rhomboids and the trapezius) for the measurement of 
PPTs. Pillows and padding were used to support the subject' s shoulder and arm when 
appropriate. The total time required to collect 3 complete sets of data for each subject 
( 4 trials total) was approximately 25 minutes. This included the time to change the 
position ofthe subject (8 times total; supine-prone-supine) as weil as the time to set up 
and stabilize the shoulder. This worked out to approximately a 5-minute rest time 
between applications of the algometer at each location. 
Tes ting 
An initial trial was perfonned at the outset of each testing session to familiarize the 
subject with the testing procedure. The data from this trial was discarded. Therea:fter, 
three complete sets of data were collected on the subject. A complete set of data 
included applying the algometer to each location (1 through 8 in sequence) and 
recording the values obtained from the location. This order of measurement was done 
two more times. Each trial (of ali 8 locations) were recorded on a single data sheet. 
Three complete sets of data were collected on each subject and at each testing 
session. When the data sheet was completed, the sheet was removed from view of 
thekinesiologistso that subsequent data sets could be collected without bias. 
Determination of the PPTs 
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At the beginning of each testing session, the subject was told that a PPT is defined as 
"the instant or moment that the pressure on the skin surface changes from the 
sensation of pressure to the sensation/perception of pain". The kinesiologist explained 
to each subject that they would feel a graduai increase in pressure on the skin. The 
pressure would continue to increase until the subject would experience a sensory 
transition from pressure to pain. The kinesiologist explained to each subject that the 
trial at a specifie location would end if the subject pressed the handheld switch or if 
the readings went beyond 400 kilopascals. This precautionary measure wasinstalled 
to avoid any unnecessary pain or damage to the skin and underlying structures. The 
kinesiologist applied the nozzle of the handheld algometer to each landmark location 
at an approximate rate of 30 kilopascals per second. The increase in the force applied 
to the skin surface was viewed by the experimenter via the digital output display on 
the algometer. The kinesiologist continued to apply pressure until the subject pressed 
the button on the handheld switch indicating that they perceived a sensory transition 
from pressure to pain. The subject never viewed the recorded values. 
Reference points: Bony landmarks 
The use of bony landmarks as anatomical reference points (McGee, 2002; Kendall et 
al., 2005) was thought to be the most appropriate method to identify the locations in the 
upper extremity and torso region. The use of a bony reference point is a common 
technique used by clinicians to locate anatomical structures due to the tremendous 
variability in body composition. For this project it would have been impractical to 
measure a specifie distance with a tape measure because of the number of locations in 
and around the scapula and the variability of the scapula' s position relative to the spinal 
colurnn. 
2.8 Statistical analyses performed in projects 
Statistical analyses were performed using IBM SPSS version19.0. 
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Projects 1 and 2 
Simple t-tests were performed between the groups and the significance was 
established at P< 0.05. Regression analysis was performed looking at the relationship 
between mean arterial pressure and waistcircurnference, as well as mean arterial 
pressure andbody fat. 
Projects 3 and 4 
A one-way ANOV A and Dunnett post-hoc analysis with significance set at P< 0.05. 
R patientswere used as the control group. CS were stratified according to age, in 
groups of 10 years. The same one-way ANOV A with Dunnett post-hoc analysis was 
performed. 
Project 5 
A one-way nova with Tukey post-hoc analysis was performed on shoulder ROM with 
significance established at P<0.05. Simple t-tests were performed on handgrip 
strength measures. Significance was fixed at P< 0.05. Pearson correlation test was 
used to evaluate relationships between outcomes measures. Significance level was set 
at P< 0.05. 
Individual and combined effects ofthe variables on the risk of neck and shoulder pain 
were examined using regression analysis. The 0.05 significance level was used as a 
guide to determine the statistical significance of the. relationship between the 
variabletime at the computer, previous pathology in the madel, and the dependent 
variable, shoulder dysfunction. 
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investigate the potential relationship between cardiovascular risk and body composition 
in both R patients and CSand to determine if any differences in cardiovascular risk 
factors existed between both groups. 
The main finding of the projectwas the significant differences across a number of 
outcome measures when comparing CS to R patients. Also evident was that waist 
circurnference changes do not reflect changes in mean arterial pressure in CS.After this 
initial study it was proposed that additional information on body composition, 
speci:fically, body fat, and muscle mass be gathered to allow for a potentially more 
robust evaluation of cardiovascular risk factors. 
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Fundamental body composition measurements is important information that can be 
utilized to determine the risk for various diseases. At the Ville-Marie MedicalCentre 
(VM Medical), kinesiologists worked side by side with the medical/oncology team to 
collect a number of base-line measurements on body composition, resting heart rate, 
and blood pressure, as part of the standard intake evaluation when female patients 
visited their physician for their annual checkup. A total of 9,315 patients were 
evaluated: 476cancer survivors (CS) and 8,839regular (R) patients.CS were more 
likely to have a higher BMI (P = 0.001) and a larger waist circurnference (P = 0.001) 
than R patients. CS were also shown to have higher blood pressure values: diastolic 
pressure of76.9 mmHg ± 10.5 VS 75.5 mmHg ± 9.9, (P = 0.01) and systolic pressure 
of 129.8 mmHg ± 17.2 VS 126.7 mmHg ±17.4 (P = 0.001) compared toR patients, 
respectively. 
Data was also stratified according to ten-year age segments. The same trends were seen 
in many of the age groups. Regression analysis looking at the relationship between 
mean arterial pressure and waist circurnference did not show any difference between 
the two groups that is CS vs R. Patients who had a higher BMI, a larger waist 
circurnference, and higher blood pressure levels, were also shown to be at greater risk 
for developing cardiovascular disease, diabetes and various musculoskeletal problerns 
as weil as an increased risk for various forrns of cancers including reoccurrence of 
previously treated cancer. 
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Changes in body composition should be considered by the medical team when planning 
preventative healthcare strategies for their patients. 
Introduction 
It has been weil established that as body composition changes with an increase in waist 
circumference and an overall increase in body mass index (BMI), there is a greater risk 
for individuals to develop various metabolic diseases such as diabetes, heart disease, as 
weil as an increased risk of developing cancer or having a reoccurrence of a previously 
treated cancer (Han et al 2006). Major health organizations, such as the World Health 
Organization (WHO), have recognized the importance of physical activity, maintaining 
ideal body size, improving dietary habits and ceasing smoking to reduce the risk of 
developing various metabolic diseases(Harvie et al 2005). Unfortunately even with 
these guidelines, many people still present with increases in total body fat, increases in 
BMI, as weil as reduced fitness levels (Flegal et al 201 0). 
A number of studies have looked at the relationship between changes in body 
composition and vital sign measures and the increase in risk for developing various 
diseases. Many studies have had to rely on patients self-reporting these measures or 
have had to rely on data extraction from records kept at multiple locations, which tend 
to result in underestimated patient body compostion values (Battaglini et al2011, Blair 
et al2011). 
Sorne researchers have used meta-analysis to evaluate the impact that body 
composition has on one's health. (Carmichael and Bates 2004). 
In our study we hypothesized that by measuring a woman's body composition and vital 
signs as part oftheir regular foilow-up care and compared the CSto the R patientsthat 
we would obtain a better understanding of the potential health risks that cancer patients 
face after undergoing cancer therapy. Thus, the main objective of this prospective study 
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was to obtain a better understanding of the body composition and vital sign measures of 
CS compared to R patients. 
Methodology 
Particpants were recruited at VM Medical. Patients waiting to meet a physician as part 
of their routine check up or de novo consult were invited to go to the adjacent VM 
Medical Integrative Health and Wellness Centre (WC) to undergo a series of tests 
administered by one ofthe resident kinesiologists. Results from tests, which included 
vital signs and body composition measurements, were entered into VM 
Medical'selectronic medical records. The information that was extracted from the 
electronic database and that was used for this study had personal information removed 
so that no individual could be identified. Each patient that came to VM Medical was 
asked to review and sign a consent form that allowed for their medical information to 
be entered into the electronic database. The electronic database was used by the 
medical team to monitor and address patient needs. This study was approved by VM 
Medical's Ethics Board and conformed to theWorld Medical Association (WMA) 
Declaration of Helsinki, Ethical Principles for Medical Research Involving Human 
Subjects. 
Testing of the patient took place in a medical evaluation room, away from the main 
clinic area. The Kinesiologist explained to the patient the purpose of the testing. A:fter 
approximately 5 minutes the patient was given the opportunity to relax and ask 
questions before the testing began. 
Resting heart rate and blood pressure values were .obtained with the use of an automatic 
blood pressure monitor (Physio logic Auto-memory 90; AMG Medical Inc., Montréal 
Canada). This monitor contains a technology called Fuzzy Logic that enables 
personalized inflation levels resulting in accurate and more comfortable readings. The 
patient' s left arm was used for testing.Ifthepatient had breast surgery on the left side of 
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their torso with lymph node( s) removed, the right arm would be used. The cuff was 
wrapped around the upper arm and the arm was supported at the level of the heart. The 
cuff was aligned with the brachial artery.Following Canadian guidelines, if 
measurements obtained on the patient were outside of expected values for the patient's 
age group, the test was repeated after a 5-minutewaitingperiod (REF, Canadian Heart 
and Stroke Foundation Guidelines) . The patient was then asked to stand in front of a 
stadiometer,a piece of equipment used for measuring height. Briefly, a stadiometer 
consists of a vertical ruler with a sliding horizontal rod that is adjusted so that it rests on 
the top of the head. The participant was asked to take in a full breath and hold it for 
several seconds while the height was recorded.Total body weight was tak:en using a 
floor scale. 
Waist and hip circurnferences were measured following the ACSM (American College 
of Sports Medicine2009) guidelines.Briefly, waist and hip circurnferences were 
obtained at the level of the greater trochanter of the hip and the umbilicus using a 
Gulick anthropometrie tape (Mississagua, Ontario Canada), respectively. Waist 
measurements were performed with the patient standing upright, feet together, and 
arms at their side while rnaintaining a relaxed breathing pattem A horizontal measure 
was tak:en at the narrowest location between the umbilicus and the sternum. The test 
was repeated two times and the average was tak:en. If there was a difference of more 
than 5 millimeters between measurements, a third measurement was taken. Hip 
measurements were performed with the patient standing upright and feet approxirnately 
10 centimeters apart. A horizontal measure was taken at the location where the buttock 
had the widest circurnference. The test was repeated two times and the average was 
taken. If there was a difference of more than 5 rnillimeters between measurements a 
third measurement was taken. 
For this study, patients were classified into two groups;cancer survivors (CS)or regular 
(R) patients. Ali of the women classified as CS underwent either a partial or a full 
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mastectomy,and may also have received adjuvant therapy such as chemotherapy, 
radiotherapy and hormonal therapy. Sorne patients may have received only one 
adjuvant therapy while other patients may have received up to three. Patients classified, 
as R.may not have had any of the adjuvant therapies mentioned above. Both the CS and 
the R patientsmay also have had other health issues for which they were taking 
additional medication that may have a:ffected outcome measurements. 
Data analysis 
Statistical analyses were performed using IBM SPSS version19.0. Simple unpaired t-
tests were performed between groups and the significance was calculated at P< 0.05. 
Pearson correlation was used to evaluate relationships between outcomes measures. 
Regression analysis was performed using Sigma plot version12. 
Results 
A total of9,315 female patients were evaluated: 476CS and 8,839 R patients. The mean 
age of each group was: CS=59.71±9.93 yrs and R=55.81±9.90 yrs (N.S., p>.05). 
Significant differences between CS and R patientsin the following outcome measures 
are shown in Table 3.1:Diastolic pressure:CS= 76.9±10.53 VS R=75.5±9.91 mmHg 
(p= .01), Systolic pressure: CS=129.8±17.18 VS R=126.7±17.42 mmHg (p= .001). 
BMI: CS=26.99±5.14 VS R=25.97 ±5.61 kg/m2 (p= .001) and waist circurnference: 
CS= 88.44±11.83 VS R=86.29±11.98 cm (P=.001). Resting heart rate was not 
significantly different between the two groups: CS= 73.25±12.82 VS R= 72.32±11.91 
bpm (p= .1 0). 
As shown in Tables 3.2 and 3.3, patients were stratified according to 10-yearage 
segments from 20-29 years to 80-89 years. At each end of the stratification there were 
only a few patients in the CS group: 1 patient in the 20-29 year segment, 7 patients in 
the 30-39 year segment and 5 patients in the 80-89 year segment. 
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Significant differences were seen in the diastolic blood pressure in the 40-49 and the 
50-59 age groups. Also, significant differences were seen in weight, BMI and waist 
circumference in the 50-59 age group. 
In the 80-89age group, CS had significantly lower measures in terms of diastolic and 
systolic blood pressure and waist circumference. 
Ali CS showed a clear trend for higher body weight, BMI and waist circumference 
measures when compared to the R patients, except for the patients in the 80-89-age 
range. 
Regression analysis of mean arterial pressure (MAP) and waist circumference was 
performed (Figure 3.1). Significant correlationsin the CS and R patientsgroupswere 
observed between MAP values and waist circumference values (r=0.16, p=.OOl and 
r=0.29, p=.001, respectively) . 
Discussion 
The CS patients'measures were shown to be significantly different from the R patients, 
with CS having higher levels of total body fat, higher BMis and greater waist 
circumferences. The CS diastolic and systolic blood pressure values were also 
significantly greater in comparison to the R patients. 
Cancer survivorsface many challenges as they undergo adjuvant therapy as part of 
cancer treatment strategies. One of the deleterious e:ffects of adjuvant therapy may 
potentially be significant changes in body composition and elevated blood pressure. In 
fact, in the present study, systolic blood pressure (SBP) for all CS, except for the 30-39 
age group (Table 3. 2) was higher than 120 mmHg,which, according to the ACSM, is 
outside the normal range. The normal range for SBP recommended by ACSM is under 
120 mmHg. This is similar to other studies that showa similar trend in ail types of 
confounded cancer patients. Also, with aging, the systolic pressure increases to rnild 
hypertensive levels. Nonetheless, in the present study, controlling for age did show that 
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both systolic and diastolic blood pressure values in CS were consistently higher than 
the R patients withthe greater risk being in the 60-69 age range (Table 3.3). 
Another confounding variable is that the elevated blood pressure ofCS might have been 
related to the medication the women were taking at the time or had previously taken 
(e.g. hormone therapy). The elevated blood pressure may also have been related to 
adjuvant therapy the women received. Our results on blood pressure are similar to those 
recently reported by other investigators that have shawn that both medication, 
including chemotherapy, and other adjuvant therapies (e.g. radiotherapy) had an effect 
on blood pressure. In their study, however, they did not report on body composition as 
we did. The study may not have accounted for any kind of medication either group may 
have been taking when blood pressure was recorded (Hojan et al2012). 
Waist circumference 
lt has been shawn that as women age and move through menopause, the levels of 
estrogen in their bodies drop. The drop in estrogen has been shawn to be linked with an 
increase in visceral fat (Feigelson et al2006). We were able to see this increase in waist 
circumference in our study in both the CS and R patients. The R patients' mean waist 
circumferences increased from 81.8 cm at 30-40 years of age to 89.5 cm at 70-80 years 
of age while the CS mean waist circumferences increased from 85.4 cm at 30-40 years 
of age to 90.00cm at 70-80 years of age. Waist circumferences were consistently 
greater for the CS group compared to R patients except at age 80-89. Many of the 
patients were already considered to be overweight. 
The BMI values obtained on the patients in this study showed that many of the women 
were not meeting the recommended guidelines put forward by the ACSM. Normative 
data out of the Cooper clinic make recommendations on waist circumference and BMI 
and stratifies people according to age group (20-29yrs, etc.). In our study, we observed 
that both the R patients and CS values exceeded the recommended guidelines. As well, 
for CS, there appeared to be on1y a small effect on mean arterial pressurewith an 
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mcrease m waist circurnference (Fig. 3.1). By contrast, the increase in waist 
circurnference in R patients appears to have a marked effect on mean arterial pressure. 
A plausible explanation is that in the lower waist circumference range the mean arterial 
pressure difference between CS and R patients was larger with the difference becoming 
smaller as waist circurnference increased. 
It is not known if the women would continue to maintain these elevated weights, BMI 
values and waist circurnferences levels as they aged. It would appear that the levels 
could increase over time unless sorne intervention was irnplemented. 
Strength of study 
We believed that by having someone on site to collect the data for the study instead of 
relying on self-reporting by the patient (weight, height and waist circurnference) gave a 
clearer picture of the patient's actual body composition. Based on the scientific 
literature, it is noted that patients tend to underestirnate their weight. We also knew 
that relying on the data extraction approach did not increase risk of error for 
measurements. We recognized that there would be a certain level of error with our data 
collection method but we believed that it would be consistent across ail patients. We 
also recognized the importance of an electronic database so that the medical team was 
able to track the body composition values of the different patients and identify which 
women were at greater risk. 
It would be interesting to see the effects of an intervention, such as counseling, while 
tracking these two groups over time to see if the patients' body composition and blood 
pressure would irnprove. Without any intervention it would be expected that bath body 
composition and blood pressure values would continue to move in a negative direction 
as bath the CS and R patients aged, with the CS potentially being more affected. 
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Limitations of the study 
One factor that may have affected the vital sign measurements of the CSmight have 
been the stress of going to the doctor' s office. We speculated that it may have been 
more stressful for the CS because they were also seeing their surgical oncologist as part 
of an ongoing follow up. The CS fear of hearing about a possible reoccurrence may 
have elevated their BP values. By contrast, the Rpatients were typically visiting the 
clinic for an appointment with their general practioner (GP) or their obstetrician and 
gynecologist (OBGYN) as part oftheir routine yearly evaluation. A second limitation 
in the study may have been the lack of diversity in the patient population that was being 
evaluated. 
Future Direction 
It would be important to evaluate the total amount of body fat, the lean muscle mass, 
and the fitness level of the cancer survivors (CS) andcompare the results to that of 
regular (R) patients. 
Conclusion 
The baseline risk assessment protocol established at VM Medical and administered by 
kinesiologists is critical in helping to understand sorne of the fundamental risks faced 
by patients. The protocol used by VM Medical kinesiologists,who were working in 
conjunction with the medical team at the centre, gave the patients a clear starting point 
as to sorne of behavior changes to be adopted by the patient to help reduce the ir risk of 
developing different forms of cancer, cardiovascular issues and metabolic diseases. 
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Table 3.1: Summary table comparing all regular (R)patients to all cancer survivors 
(CS) 
O u tcome Measures R cs F- value Sig. 
n=8839 n=476 (2-tailed) 
BP Diastolic 75.52 76.85 4.339 0.01 
SD 9.912 10.53 
BP Systolic 126.70 129.83 0.009 0.00 
SD 17.42 17.18 
Heart Rate(BPM) 72.32 73 .25 2.103 0.10 
SD 11.91 12.82 
Mean Arterial Pressure(mmHg) 92.14 93 .72 1.33 0.01 
SD 12.85 14.27 
Weight (kg) 67.49 68 .97 0.001 0.02 
SD 13.71 13.54 
Height (cm) 161.18 159.64 0.883 0.00 
SD 6.76 6.41 
BMl 25.97 26.99 0.002 0.00 
SD 5.61 5.14 
Waist circumference (cm) 86.29 88.44 0.873 0.00 
SD 11.98 11.83 
P <0.05, type CS= cancer survivors, typeR = regular patients, Standard deviation = SD () 
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Table 3.2:Anthropometric and vital signs measures stratified by 10-yr age groups 
(20 to 59 years) fo r regular (R) patients and cancer survivors (CS) 
R cs R cs R cs R cs 
Outcome Measures 20-29 20-29 30-39 30-39 40-49 40-49 50-59 50-59 
n=lO n=l n=255 n=7 n=2311 n=78 n=3224 n=140 
Mean weight(kg) 57.69 57.00 65 .14 67.08 67.00 67.23 67.73 70.91* 
SD 11.32 0.00 13.25 7.26 14.30 14.22 13 .86 14.87 
Mean BP Diastolic (mmHg) 69.70 76.00 71.92 78.14 74.68 78 .17* 76.14 78.27* 
SD 5.68 0.00 8.80 9.75 9.89 10.76 9.79 9.92 
Mean BP Systolic (mmHg) 113.00 129.00 115.65 119.14 119.94 121.33 125.36 127.57 
SD 10.51 0.00 11.48 7.86 14.72 16.51 15.77 15.07 
MeanArterial Pressure (mmHg) 76.48 93 .76 86.50 91.81 89.34 92.56* 92.68 93.35 
SD 26.15 0.00 8.94 8.94 12.32 11 .76 12.61 15.43 
Meanheartrate(BPM) 78.50 79.00 73 .46 71.86 72 .22 72.37 72.17 74.06 
SD 12.64 0.00 11.34 12.08 11.83 13 .63 11.96 12.29 
MeanBMl 21.28 21.20 24.28 25.79 25.19 25.48 25.96 27.01 
SD 3.47 0.00 5.28 3.68 5.52 5.32 5.60 5.57 
Waist circumference (cm) 74.40 76.00 81.82 85.39 83.79 86.02 86.12 88.14* 
SD 6.07 0.00 10.42 6.96 11.79 11.55 11.85 7.48 
Signijicance set P<0.05, Standard deviation= SD, * Significant difference between CS and R with CS being signi fi cantly 
greater tban R values 
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Table 3.3:Anthropometric and vital signs measures stratified by 10-yr age groups 
(60 to 89 years) for regular (R) patients and cancer survivors (CS) 
R cs R cs R cs 
Outcome Measure 60-69 60-69 70-79 70-79 80-89 80-89 
n=2184 n=162 n=753 n=82 n=l02 n=S 
Mean weight(kg) 68.36 68.83 66.97 68.29 62.71 63.44 
SD 13.16 12.48 12.83 11.98 12.24 6.81 
Mean BP Diasto1ic (mmHg) 76.23 76.24 74.85 75 .16 74.42 62.60** 
SD 9.79 10.95 10.09 9.90 10.58 9.84 
Mean BP Systo1ic (mmHg) 132.41 133.54 138.24 135.56 143.73 126.00** 
SD 18.36 17.16 17.67 17.95 16.43 16.93 
Mean Arteria1 pressure(mmHg) 94.53 94.76 95.47 94.14 97.52 83 .73** 
SD 13.15 14.11 13 .05 15.24 10.75 11.76 
Mean heart rate (BPM) 72.79 73 .21 71.42 72.74 72.37 74.80 
SD 11.88 13.65 12.07 11.50 12.15 13.55 
MeanBMl 26.66 27.46 26.95 27.81 26.64 24.48 
SD 5.37 4.90 5.99 4.81 7.12 2.13 
Waist circumference (cm) 88.47 89.39 89.53 90.00 90.41 84.86** 
SD 11.70 12.85 12.27 9.53 11.72 4.25 
Significance set ?<0.05, Standard deviation= SD, **Significant difference between CS and R with cs being 
significant fy less !han R values 
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Figure 3.1: Relationship between mean arterial pressure and waist circumference in 
regular (R) patients and cancer survivors (CS) 
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This manuscript was presented in part as a poster at the 2012 Annual Meeting of 
theAmerican Colle ge of Sports Medicine. The primary goal of thesecond study was to 
include a more detailed analysis of body composition including body fat, and muscle 
mass in breast cancer survivors, while the secondary goal was to evaluate more closely 
the relationship between body fat and blood pressure. 
The main findings of the studywerethe significant di:fferencesobserved in outcome 
measuresofbody fat, muscle mass and total water between cancer survivors (CS) and 
regular (R) patients. Also, percent body fat seems to be a better indicator of changes in 
mean arterial pressure (MAP) for CS. Nonetheless, additional information about 
different treatment protocols that cancer patients may undergo would be required to 
gain a better understanding of body composition changes in CS. 
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The goal of this study was to standardize the anthropometrie and blood pressure 
measurements performed as part of the intake evaluation of the patients at the Ville-
Marie Medical Integrative Health and Wellness Centre (WC). 
The investigators believedthat these measurements could help identify women who are 
at greater risk for developing cardiovascular disease. 
The women were divided into two groups. The fust group, cancer survivors(CS) 
received sorne form of treatment associated with breast cancer while the second group, 
regular (R)patients did not receive any kind of cancer treatment. 
CSand R patients were evaluated collectively as a group and then strati:fied according to 
age. Outcome measures showed significant differences between CS and R patients 
with regards to blood pressure, body fat and lean muscle mass values. 
Regression analysis of mean arterial pressure and percent body fat showed a similar 
relationship between CS and R patients. CS patients,however, appeared to be at greater 
risk for developing cardiovascular disease and diabetes compared to R patients. 
Introduction 
The percentage of the general population affected by obesity in North America has 
increased substantially since the 1960s (De Schutter et al 2013) with levels now 
reaching 34% among adults and 17% among children and adolescents (Flegal et al 
2010, Rëbl et al2013). This increase in obesity has been linked to changes in lifestyle 
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and changes in work and living environments resulting in a decrease in physical 
activity (Rôbl et al2013). This has not necessarily meant that people have more or less 
time in their daily lives to participate in recreational activities, but rather that they have 
become significantly busier and more focused on performing less metabolically 
demanding activities, such as spending more time performing more mentally 
challenging activities.Oftentimes,this has resulted in increased levels of stress(Claire 
Wang et al2013). 
Evidence exists indicating a probable protective effect physical activity has on reducing 
breast (Sheean PM, Hoskins and Stolley, 2012)and endometrial cancers (Carmichael 
and Bates, 2004, Calle and Kaaks, 2004) with risk reductions ranging from 20 to 30%. 
Major health organizations such as the World Health Organization have recognized the 
importance ofphysical activity (Franceschi and Wild, 2013), maintaining ideal body 
size, improving dietary habits, and ceasing smoking and their effect on reducing the 
risk of developing metabolic disease(Li Yuquig, 2012). Unfortunately, even with these 
guidelines many people are still presenting with increases in total body fat, decreases in 
lean muscle mass and reduced levels of fitness. 
Adipose tissue is considered a dynamic endocrine organ. It stores triglycerides, which 
provides energy to the body (Guyton and Hall, 2000) and insulation to protect against 
cold. However, excessive amounts of adipose tissue has been shown to significantly 
alter hormone metabolism which has been linked to different kinds of 
cancer.(Grossmann et al, 2010). The 2012 World Cancer Congress held in Montreal, 
Canada noted the importance of reducing body weight and working towards ideal 
body size, increasing levels of physical activity, improving overall diet and 
eliminating tobacco usage as preventative means to decrease the risk of cancer 
occurrence and reoccurrence (Jarde et al, 2011). This is consistent with a number of 
studies that have looked at adiposity and the risk factor that is associated with 
developing colorectal, breast (post-menopausal), endometrial, esophageal 
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( adenocarcinoma), pancreatic, and kidney cancers (Parek:h, Chandran and Bandera, 
2012). 
We believe that although many people know the benefits of maintaining lower body 
weight and lower body fat, they are still not achieving the recommended targeted 
levels. We believe those oncology patients who are at risk for reoccurrence of cancer 
are also increasing their risk for cardiovascular and metabolic diseases such as diabetes. 
Methodology 
As part of the standard intake evaluation, patients waiting to meet with one of the 
physicians at VM Medical underwent a series of tests administered by one of the 
kinesiologists working at the WC. Results from tests, which included vital signs and 
body composition measurements, were entered into VM Medical's electronic medical 
records. The information that was extracted from the electronic database and that was 
used for this study had personal information removed so that no individual could be 
identified. Each patient who came to VM Medical was asked to review and sign a 
consent form that allowed for their medical information to be entered into the electronic 
database. The medical team used the electronic database to monitor and address patient 
needs. This study was approved by the VM Medical Ethics Board and conformed to the 
World Medical Association (WMA) Declaration of Helsinki, Ethical Principles for 
Medical Research Involving Human Subjects. 
As part of the preparation for testing, patients were asked to refrain from smoking or 
drinking caffeine products for 4 bours prior to testing. Before testing began, patients 
were asked if they needed to go to the wasbroom to void any fluids. Testing of the 
patient took place in a medical evaluation room, away from the main clinic area. The 
kinesiologist explained to the patient the purpose of the testing. A:fter approximately 5 
minutes the patient was given the opportunity to relax and ask questions before the 
testing began. 
44 
Resting heart rate and blood pressure values were obtained with the use of a 
Physiologie Auto-memory 90 instrument (AMG Medical Inc., Montréal Canada) 
(Figure 4.1). The patient's left arm was used for testing. If the patient had breast 
surgery on the left side oftheir torso with lymph node(s) removed, the right arm was 
used. The cuffwas wrapped around the upper armand was supported at the level of the 
heart. The cuff was aligned with the brachial artery. If measurements obtàined on the 
patient were outside of expected values for the patient's age group, the test was 
repeated after a 5-minute waiting period. The patient's height and weight were 
measured using a stadiometer and weight scale respectively. 
The In-Body 230 (Seoul, Korea) (Figure 4.2) impedance unit was used to determine 
body weight, percent .body fat, lean muscle mass, and total body water. The patient was 
asked to remove their shoes and socks and any extemal metal objects (e.g. watches, 
rings) that might affect the results. The patient then stood on the foot pads of the unit 
while holding onto the extemal handles so that data could be collected. The 
kinesiologist collected the information from the display monitor (Karelis et al2013). 
Waist circumference was taken using a Gulick anthropometrie tape (Mississagua, 
Ontario Canada) and the ACSM (American College of Sports 
Medicine2013)recommended methodology. Waist measurements were performed with 
the patient standing upright, feet together, and arms at their side while maintaining a 
relaxed breathing pattern. A horizontal measure was taken at the narrowest location 
between the umbilicus and the sternum. This location was typically 2.5 cm above the 
umbilicus. The test was repeated twice and the average was taken. If there was a 
difference of more than 5 millirneters between measurements, a third measurement was 
taken. 
For this study, patients were classi:fied as either being cancer survivors (CS) or regular 
(R) patients. Ali of the women classi:fied as CS underwent either a partial or a full 
mastectomy, and may have had additional forms of adjuvant therapy, for example, 
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chemotherapy, radiotherapy, and/or hormonal therapy. Sorne patients may have had 
only one additional therapy while other patients may have had as many as three forms 
of adjuvant therapy. Patients classified as R would not have had any of the adjuvant 
therapies listed above. Both the CS and the R patients may also have had other health 
issues and may have been taking additional medication, which may have a:ffected 
outcome measurements. 
Data analysis 
Statistical analyses were performed using IBM SPSS version19.0.Simple t-tests were 
performed between the groups and the significance was calculated at P< 0.05. 
Regression analysis was performed looking at the relationship between mean arterial 
pressure and body fat. 
Results 
A total of 1,596 patients were evaluated: 262 cancer survivors (CS) and 1,334 regular 
(R) patients. The ages of the patients were CS (Il= 59.86 yrs. SD= 9.83) and R (Il= 
54.27 yrs. SD= 9.10). 
Analysis showed a significant difference between CS and R patients as can be seen in 
the following outcome measures (also see Table 4.1), P <0.05. 
Diastolic blood pressure CS (Il= 76.69 mmHg, SD= 9.98) vs R (!l=74.46, SD= 9.30), 
Systolic blood pressure CS (Il= 130.52 mmHg SD= 16.04)vs R (!l=124.87 SD= 16.04) 
Arterial pressure CS (Il= 93.93 mmHg SD= 13.51) vs R (!l=90.99 SD= 11.66),Resting 
heart rate CS (Il= 72.78 bpm SD= 12.44) vs R (!l=71.21 bpm, SD=11.62), BMI CS 
(!l=26.74 SD 5.14) R (!l=25.81 SD= 4.94),Muscle mass CS (!l=10.94kg SD = 1.67) 
vsR ().!=11.22 kg, SD=1.48),Percent body fat CS (Il= 37.71, SD = 7.39) vs R (!l=34.88 
SD= 8.31) and Waist circumference CS (Il= 87.84cm SD=10.86) vs R (!l=84.90 SD= 
11.24). Total body water CS (Il= 30.02kg, SD =3.91) vs R (Il= 30.79kg, SD = 3.70) 
was not significantly different between the two groups (Table 4.1) 
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Patients were then stratifi.ed according to age in 1 0-year segments, starting with 20-29 
years of age up to 80-89 years of age. At each end of the stratification there were only a 
few patients in the CS group: 1 patient in the 20-29 year range, 7 patients in the 30-39 
year range, and 5 patients in the 80-89 year range. 
Significant differences were seen in diastolic blood pressures in the 30-39, 40-49 and 
50-59 age ranges while mean arterial pressure was significantly different for the 30-39 
and 40-49 age groups Percentage body fat was notably different between CS and R 
patients in the 40-49, 50-59, 60-69 and 70-79 age groups. Mean muscle mass was 
lower in CS in the 40-49 and 60-69 age groups (Tables4.2 and 4.3). 
Regression analysis showed that the relationship between MAP values and body fat 
was very similar for both groups: CS 1=0.04, p< 0.001 ; 0.34x+81.38 (Figure 4.3) and 
R 1= 0.05, p< 0.000; 0.32x+ 79.78 (Figure4.4). 
Discussion 
We know that basic anthropometrie and cardiovascular measures are taken at many 
medical facilities on a regular basis and often entered into patient charts. By having the 
same individuals obtain ali the measurements via a .standardized process and entering 
them into a central electronic database we believe that we have a better understanding 
of sorne of the challenges faced by the women at the WC and will ultimately pro vide us 
with more specifie information on healthy lifestyle habits. 
Through the use of the body impedance tool, detailed information was obtained on how 
body composition differed between the two groups. We were aware that bioimpedance 
measurements have been shown to overestimate (American College of Sports 
Medicine2013) the total amount of body fat by 3-4% for an individual in comparison 
to a DEXA measurement (American College of Sports Medicine 2013). One of the 
goals of this project was to implement a protocol that would make it easy for many 
facilities to utilize and implement the patient screening process. We were also aware 
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that a number of the cancer survivors had already received a significant amount of 
radiation associated with their adjuvant therapy. Thus, it was important to utilize a 
measuring tool that would carry minimum to no risk for the patient, whether actual or 
perceived. 
The data obtained in this study was similar to that obtained in our previous work (Jones 
et al 2013, Manuscript 1). The CS were shawn to have higher blood pressure values 
and poorer body composition traits in comparison to the R patients. The literature 
clearly shows the potential for elevated risk of developing different and recurring forms 
of cancer, i.e., an increased risk of developing type two diabetes as weil as developing 
cardiovascular issues related to an increase in blood pressure values and increase in 
levels ofbody fat (Blair et al2012, Brown and Simpson 2010). 
The data shows that many of the patients' outcome measures are not within the 
recommended guidelines put forward by the ACSM (American Coilege of Sports 
Medicine).The ACSM providesnormative data as weil as recommendations for percent 
body fat, waist circurnference and BMl. 
CS were shawn to have significantly lower levels of lean muscle mass compared to the 
R patients. We would expect that this group might be at greater risk for developing 
sarcopenia, which is the age-related loss of muscle and :function (Di Sebastiano and 
Mourtzakis 2012). It is likely that lasses in strength may occur prior to any detectable 
changes in lean mass. Muscle quality, a ratio of strength to lean mass, may account for 
changes in both variables for early detection of sarcopenia. 
With the increase of total body fat in cancer survivors, it is not unreasonable to assume 
that this group is also at risk for developing metabolic problems such as cardiovascular 
disease and diabetes. 
It is not readily apparent why there was a significant difference between the two 
groups. The cancer survivors were challenged to undergo treatment to reduce or try to 
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eliminate the spread of the cancer tumor and cells from their bodies. Different 
treatment protocols might have a:ffected outcome measures. We expected different 
types of surgery, as weil as the use of chemotherapy, radiotherapy and/or hormone 
therapy might have had adverse effects on outcome measures. This information was not 
available to the research team at that stage. 
Other factors that might also have accounted for this difference include: 1) Lack of 
direction from the medical team as to what should be done to address changes in body 
composition ; 2) A fear by the patient to undertake any type of pro gram which might 
aggravate their condition; 3) Lack of encouragement or possible discouragement from 
undertaking an exercise program other than walking; 4) The patient might not have 
been an habitually active individual; 5) Perhaps the patient attempted to become active 
but became discouraged and stopped like many people often do. Though exercise 
during cancer therapy has been encouraged in recent years, there is still sorne 
reservation about undertaking an exercise program. 
Sorne of the limitations for this project included not knowing the type of medication 
that the patients were ingesting prior to and during the testing. In both instances, this 
would be cause for confounding variables in the study's outcome measures. 
Medications that could have irnpacted our findings may have included patients taking 
beta blockers and diuretics (Boxall and Clark 2012). It is not unreasonable to expect 
that as patients age they may begin taking these medications as part of a preventative 
treatment protocol. This would influence the measures for both CS and R patients. 
As individuals age they tend to show an increase in body fat, a decrease in lean muscle 
mass, and an elevation in blood pressure. It was expected that patients in both groups 
might be utilizing medication such as beta blockers and statins to address elevated 
blood pressure and cholesterol values. The possibility that they might be taking 
additional medications to control other medical issues were also considered, for 
example, sorne of the cancer survivors might have been taking hormones such as 
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Tamoxifen and Arimedex(Hojan et al2012). This would affect body composition and 
vital sign values, such as blood pressure. 
One other factor, which might have influenced heart and blood pressure values, in 
particular for the cancer survivor group, was the anticipation (anxiety) of going to the 
doctor's office. For sorne patients this is a stressful visit, e.g., white coat syndrome. 
This may have been particularly relevant for the cancer survivors who are often 
concemed about a potential reoccurrence oftheir cancer. 
The next step in our project is to continue to collect the anthropometrie and 
cardiovascular measurements to see how ali treatments (therapies and medications) 
may be influencing the measures collected for bath CS and R patients. We would also 
like to know what would happen to bath groups as they age i.e. Do their values 
continue to change significantly over time? We believe that the CS need to be followed 
much more closely than what was previously thought. 
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Table 4.1: Group Statistics for ali patients 
Outcome Measure R cs F Significance 
n= 1334 n=262 Va lue P< 0.05 
Age 54.27 59.86 3.08 0.00 
SD 9.10 9.83 
Mea n weight(kg) 67.12 68.65 0.3 1 0.08 
SD 13.16 13.25 
Mea n height(cm) 161.2 1 158 .23 7.30 0.00 
SD 6.25 14.07 
Mea n BP Diastolic (mmHg) 74.46 76.69 2.06 0.00 
SD 930 9.98 
Mea n BP Systo lic (mmHg) 124 .87 130 .52 0.24 0.0 1 
SD 16.04 16.04 
Mea n Arteria iPressure(mmHg) 90.99 93.93 0.84 0.00 
SD 11 .66 13.51 
Mea n hea rt rate (BPM) 7 1.2 1 72.78 1.26 0.05 
SD 11.62 12.44 
Mea n BMI 25.8 1 26.74 0.59 0.0 1 
SD 4.94 5.14 
Mea n Muscle Mass (kg) 11.22 10.94 0.04 0.0 1 
SD 1.48 1.67 
Mean % body fa t 34 .88 37.71 3.80 0.00 
SD 83 1 7.39 
Mea n total body wa ter (kg) 30 .79 30.02 0.11 0.00 
SD 3.70 3.9 1 
Wa ist circum fe rence (cm) 84 .90 87.84 0.53 0.00 
SD 11 .24 10.86 
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Figure 4.1: Physiologie Auto-memory 90 (Measures resting heart rate and blood 
pressure) 
Figure 4.2: In-Body 230 (Body Composition Analyzer) 
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Table 4.2: ()utco rne rneasures f o r regular (R) patients and cancer SUIVI VOrS (CS) 
(Ages 20 to 59) 
R cs R cs R cs R cs 
Outcome Mcasure 20-29 20-29 30-39 30-39 40-49 40-49 50-59 50-59 
n=IO n=l n=255 n=7 n=2311 n=78 n=3224 n=l40 
Mean weight(kg) 57.15 57.00 65.04 67.23 66.59 66.95 67.29 70.83 
SD 9.69 0.00 13.51 7.94 13.85 13.10 13.13 15.13 
MeanBP Diastolic (mmHg) 68.50 76.00 70.10 80.33* 73 .72 78.45* 75.20 78.16* 
SD 0.71 0.00 6.55 6.81 9.21 10.01 9.43 9.98 
MeanBP Systolic (mmHg) 114.50 129.00 114.51 122.00 118.65 122.81 125.05 127.91 
SD 2.12 0.00 8.77 8.89 13.43 16.91 15.27 14.37 
MeanArterial Pressure(mmHg) 83 .84 93 .67 84.90 94.22* 88 .22 93.24* 91.64 93.59 
SD 0.23 0.00 6.67 7.50 11.88 11.54 11.34 14.75 
Mean heart rate (BPM) 71.50 79.00 71.51 70 .. 33 71.44 72.83 71.27 73 .69 
SD 12.64 0.00 11.34 12.08 11.83 13.63 11.96 12.29 
MeanBMl 21.05 21.20 24.35 26.10 25.05 4.97 25.48 25.99 26.94 
SD 2.33 0.00 4.70 3.73 4.87) 4.96 5.68 
MeanMuscleMass (kg) 10.56 10.96 11.83 10.94 11.65 11.51 11.18 11.31 
SD 1.06 0.00 2.00 0.96 1.61 2.78 1.39 1.39 
Mean % body fat 28.75 26.20 31.40 37.23 32.19 35.67* 35.42 36.51 * 
SD 5.73 0.00 7.08 8.50 8.29 7.25 8.48 7.54 
Mean total body water (kg) 28.93 30.12 31.30 29.93 30.61 31.87 30.74 31.16 
SD 2.45 0.00 4.02 2.28 3.77 4.15 3.80 3.85 
Waist circumference (cm) 71.50 76.00 79.77 83 .67 82.82 85.16 85.02 87.52 
SD 2.12 0.00 10.81 4.73 11.21 10.45 11.05 12.52 
Significan/ d!lference between CS and R with CS * Significance sel P<O. 05, Standard deviation= SD, 
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Table 4.3: C>utcorne rneasures for regular (R) patients and cancer survivors (CS) 
(Ages 60-89) 
R cs R cs R cs 
Outcome Measure 60-69 60-69 70-79 70-79 80-89 80-89 
n=2184 n=162 n=753 n=82 n=102 n=S 
Mean weight(kg) 68.28 68.29 65.05 68.52 58.60 64.53 
SD 12.17 12.18 11.57 13 .20 4.55 6.89 
Mean BP Diastolic (mrnHg) 75.10 75.83 73 .20 74.74 78.00 66.30 
SD 9.39 10.34 9.16 9.03 9.90 11.85 
Mean BP Systolic (mrnHg) 130.88 133.59 137.75 136.26 145.00 132.67 
SD 16.98 16.29 15.67 17.78 15.56 17.50 
Mean Arterial pressure(mrnHg) 93.39 94.07 94.72 95 .25 100.34 88.44 
SD 11.97 14.95 9.84 10.36 11.78 13.32 
Mean heart rate (BPM) 71.21 72.37 69.25 12.88 71.87 70.50 74.67 
SD 12.10 11.44 ll.41 6.89 13 .44 
MeanBMI 26.69 27.30 25.95 28.02* 24.90 25.07 
SD 4.84 4.91 4.61 4.88 0.42 2.22 
Mean Muscle Mass (kg) 10.94 10.61 * 10.23 10.35 10.56 10.88 
SD 1.25 1.34 1.20 1.06 0.44 1.17 
Mean %body fàt 37.31 39.07* 37.59 39.87* 34.55 34.77 
SD 7.26 7.04 7.53 7.33 2.48 1.66 
Mean total body water(kg) 30.12 29.31 28.12 28.74 29.15 29.15 
SD 3.35 3.65 3.37 2.93 0.82 3.43 
Waist circumfèrence (cm) 87.71 88.75 86.77 11.01 89.64 92.00 85.33 
SD 10.97 10.19 9.68 7.07 5.03 
Significance set ?<0.05, Standard deviation- SD, **Significant di.fference between CS and R wilh CS being 
significantly less than R values 
Figure 4.3: Regression analysis o:fi:nean arterial pressure and body fat in cancer 
survivors (CS) 
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Figure 4.4: Regression analysis o:fmean arterial pressure and body fat in regular(R) 
patients 
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CHAPTERV 
MANUSCRIPT NUMBER 3 
5.1 Overview of the third manuscript 
This manuscript, along with manuscript number 1, was presented as part of the research 
poster presentations at the annual conference of the National Consortium of Breast 
Cancer Centers 2013. 
Patients in this manuscript were stratified based on the type of surgical intervention 
they had undergone. The surgical interventions were partial mastectomy, full 
mastectomy, bilateral surgery, unilateral reconstruction and bilateral reconstruction. 
The main finding was that the more significant the surgical intervention, the more 
lik:ely the patient would have an elevated risk for cardiovascular disease. 
5.2 Manuscript 3:Impact of different surgical interventions on anthropometrie 
andvital sign measurements in breast cancer survivors 
Abstract 
The Ville-Marie Medical Integrative Health and Wellness Center (WC) monitors 
body composition, physical activity and vital signs of both regular (R) patientsand 
cancer survivors (CS) as part oftheir patients' annual mammography screening. 
Objective 
The objective of the study was to determine whether or not body composition and 
baseline cardiovascular function of R patients is in contrast with CSwho have 
undergone surgical interventions. 
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Metbods 
Baseline measurements were taken on 3,694 female R patients and 712 CS (for a total 
of 4,406 screened patients) at VM Medical. These measurements included Body 
Mass Index (BMI), resting heart rate, blood pressure, percent body fat, muscle mass, 
total body water, and waist circumference. CS were stratified into 5 groups (see Table 
5.1) according to surgery type (ST). ST groups were compared toR patients. A one-
way ANOVA was performed followed by a Dunnett's post hoc analysis. Significance 
was set at p < .05. 
Results 
Significant differences were seen between ST groups and the R patients (p= 0.001) 
for eight key variables. 
Conclusion 
Surgical intervention for breast cancer is vital, however, certain surgical protocols 
appear to be associated with an increase in negative body composition and blood 
pressure outcomes. Thus, it seems important that follow-up medical teams encourage 
CS patients to engage in healthy lifestyle habits to help modify these negative 
outcomes before they become even more critical. 
Introduction 
When a suspicious mass is found in the breast, surgery to remove the tumor is an 
important tool used to minimize its potential impact on the body. However, surgery 
and ali of the interventions associated with surgery, do have an impact on the body as 
a whole. Complications after surgery have been shown to have a significant impact 
on the recovery of the individuals. Complications have been grouped into three 
categories: major surgical complications, wound complications, and medical 
complications (Fischer et al2013). Work has also been done regarding complications 
that occur with breast reconstruction in particular loo king at the use of expanders and 
implants or the patient's own soft tissue (TRAM - transverse rectus abdominus 
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musculocutaneus) and the post-surgical complications that may follow(Christensen et 
al. 2013). The short term impact of these complications is often brought to the 
immediate attention of the medical team. The same attention is not always present 
with sorne of the long term challenges for the patients post-surgery. We have 
o bserved that as women undergo cancer treatment the ir blood pressure and body 
composition may change. The changes in body composition and blood pressure may 
place these women at risk for other underlying problems such as cardiovascular and 
metabolic disease. There is a strong association between negative changes to both 
body composition and cardiovascular risk factors and the impact this has on a 
person's mobility (Flegal et al. 2010). As an individual's mobility diminishes they 
tend to become more dependent on family, friends and social services to fulfill sorne 
oftheir daily functions. 
It is not clear to us how different types of surgery affect these women in the long 
term. We would expect that as the women have more invasive surgery or repeated 
surgeries that this would have a negative effect on the outcome measures for 
cardiovascular and metabolic disease. The goal of this investigation was to perform 
basic body composition measurements on patients who have undergone breast 
surgery to determine if there were changes in blood pressure and body composition 
values. 
Methodology 
As part of the standard intake evaluation, patients waiting to meet with one of the 
physicians at VM Medical underwent a series of tests administered by one of the 
kinesiologists working at the VM Medical Integrative Health and Wellness Centre 
(WC). Test results, which included vital signs and body composition measurements, 
were entered into VM Medical's electronic medical records. Each patient who came 
to VM Medical was invited to review and sign a consent form that allowed for their 
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medical information to be entered into the database. The medical team uses the 
database to monitor and address patient needs. 
The information that was extracted from the database, and that was used for this 
study, was stripped of persona! information so that no individual could be identified. 
The study was approved by the VM Medical Ethics Board and conformed to 
theWorld Medical Association (WMA) Declaration of Helsinki, Ethical Principles for 
Medical Research Involving Human Subjects. 
As part of the preparation for testing, the patients were asked to refrain from smoking 
or drinking caffeine products for 4 hours prior to testing. Before testing began, 
patients were given the opportunity to use the washroom to void any fluids. Testing 
took place in a medical evaluation room, away from the main clinic area. The 
kinesiologist explained to the patients the purpose ofthe testing. A:fter approximately 
5 minutes, patients were given the opportunity to relax and ask questions before the 
testing began. 
Resting heart rate and blood pressure values were obtained through the use of a 
Physiologie Auto-memory 90 instrurnent(AMG Medical Inc., Montréal Canada) . The 
patient' s left arm was used for testing. If the patient had breast surgery on the left side 
of their torso with lymph node(s) removed, the right arm was used. The cuff was 
wrapped around the upper arm and the arm was supported at the level of the heart. 
The cuff was aligned with the brachial artery. If measurements obtained on the 
patient were outside of expected values for the patient's age group, the test was 
repeated after a 5-minute waiting period. 
The patient's height and weight were measured using a stadiometer and weight scale 
respectively.The In-Body 230(Seoul, Korea) impedance unit (Karelis et al2013) was 
used to determine body weight, percent body fat, lean muscle mass, and total body 
water. The patient was asked to remove ber shoes and socks as well as to remove any 
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external metal abjects (e.g. watches, rings) which might affect the results.The patient 
then stood on the foot pads of the unit while holding onto the external handles so that 
data could be collected. The kinesiologist then documented the information from the 
display monitor. 
Waist circumference was taken using a Gulick anthropometrie tape (Mississagua, 
Ontario Canada) and followed ACSM (American College of Sports Medicine 2008) 
methodology. Waist measurements were taken with the patient standing upright, feet 
together, and arms at their side while maintaining a relaxed breathing pattern. A 
horizontal measure was taken at the narrowest location between the umbilicus and the 
sternum. This location was typically 2.5 cm above the umbilicus. The test was 
repeated twice and an average was taken. If there was a difference of more than 5 
millimeters between measurements, a third measurement was o btained. 
For this study patients were classified into to groups;cancer survivors (CS) or regular 
(R) patients. All of the women who were classified as CS underwent either a partial 
or a full mastectomy, and may havereveived adjuvant therapy, such as chemotherapy, 
radiotherapy and hormonal therapy. Sorne patients may have received only one 
adjuvant therapy while other patients may have received up to three.Patients 
classified as regular (R) patients may not have had any of the adjuvant therapies 
mentioned above. Both the CS and the R patients may also have had other health 
issues and may have been taking additional medication that may have affected 
outcome measurements. 
CS were stratified according to one of five common surgi cal interventions 1) a partial 
mastectomy; 2) a full mastectomy; 3) bilateral surgery; 4) bilateral full mastectomy; 
and 5) a unilateral reconstruction (which may have occurred on the same day as the 
full mastectomy or on a different day) or, bilateral reconstruction (which may have 
occurred on the same day as the bilateral full mastectomy or on a different day). 
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Data analysis 
Statistical analyses were performed using IBM SPSS version 19.0,a one-way 
ANOVA and Dunnett post-hoc analysis; significance calculated at P< 0.05. The R 
patients were used as the control group. Patients were also stratified according to age, 
in groups of 10 years. The saine one-way ANOVA with Dunnett post-hoc analysis 
was performed. 
Results 
The mean age of CS varied from 56-63 years of age compared to the mean age ofthe 
R patients which was 55 years of age. The patients in the unilateral reconstruction 
category had a mean age close to the R patients at 56 years of age.(As per Methods) 
BMI 
Body composition values followed the same pattern as the blood pressure values. 
Body mass index (BMI) values were highest in the fullmastectomy group (27.12 SD 
5.81) and were the lowest in the R patients group (26.07 SD 5.16). There was not as 
marked a difference between the groups as with other measurements (Table 5.1). 
Resting Heart Rate 
Resting heart rate values were highest in the fullmastectomy group (78.02 bpm SD 
13.72) and were the lowest in the bilateral reconstruction group (64.20 bpm SD 9.39) 
(Table 5.1). 
Blood Pressure 
Blood pressurevalues were shawn to increase with thetype of surgery. Diastolic blood 
pressure values were highest in the unilateral reconstruction group (79 .14 mmHg SD 
10.68) and were lowest in the bilateral reconstruction group (73.60 mmHg SD 8.44). 
Systolic blood pressure values were highest in the full mastectomy (132.58 mmHg 
SD 17.39) and the bilateral surgery (132.93 mmHg SD 15.72) groups. The lowest 
systolic blood pressure values were in the bilateral reconstruction group (120.80 
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mmHg SD 22.13). Mean arterial pressure values were highest in the unilateral 
reconstruction group (95.49 mmHg SD 11.06) and were the lowest in the bilateral 
reconstruction group (89.33 mmHg SD 12.07) (Table 5.1). 
Body Fat 
Percent body fat values were highest in the fullmastectomy group (38.09% SD 7.15) 
and were the lowest in the bilateral reconstruction group (30.03% SD 8.24) (Table 
5.1). 
Mean Muscle Mass 
Mean muscle massvalues were highest in the unilateral reconstruction group ( 11.87 
kg SD 1.35) and were the lowest in the bilateral reconstruction group (10.57 kg SD 
2.29). Total body water values were highest in the unilateral reconstruction group 
(32.64 kg SD 3.66) and were the lowest in the bilateral reconstruction group (29.26 
kg SD 5.49) (Table 5.1). 
Waist Circumference 
Waist circumference values were highest in the bilateral surgery group (87.79cm SD 
8.83) and were the lowest in the bilateral reconstruction group (82.20 cm SD 11.82) 
(Table 5.1). 
Patients were also stratified by age and type of surgery. The 40-49 years age group, 
Table 5.2, and the 50-59 years age group, Table 5.3, showed significant differences 
between their outcome values when compared to the R patients. Age groups 60-69 
years, Table 5.4 and 70-79 years, Table 5.5, showed the same trend but there was not 
a significant difference in the outcome measures between these groups. 
Discussion 
In general, patients who underwent surgery i.e CS had significantly poorer results 
compared to the regular (R)patients. Three different categories of the CS group were 
shown to have significantly different outcome measures in comparison to the R 
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patients control group. The CS categoriesincluded patients who underwent a partial 
mastectomy, a full mastectomy or aunilateral reconstruction. Generally, the more 
invasive the surgical intervention was for the women, the greater the impact was on 
the outcome measures. The patients who underwent a full mastectomy had poorer 
measures compared to the women who underwent a partial mastectomy. Patients who 
underwent unilateral reconstruction had the poorest diastolic and mean arterial 
pressure values than ali other CS categories. Body composition values were affected 
in this group but not as severely as in other groups. Sorne of the patients in the 
unilateral reconstruction group may have had only one surgery, where both the 
surgical oncologist and the plastic surgeon would have been present. The patients in 
this category may also have had two more surgeries. The frrst surgery would have 
been with the surgical oncologist, to remove the turnor and sample the lymph node(s). 
The second surgery and possibly subsequent surgeries would have been with the 
plastic surgeon. This may account for sorne of the elevated values that were 
measured. 
With the limited number of patients in the bilateral full mastectomy categoryand 
bilateral reconstruction category, it was difficult to draw substantive conclusions. One 
notable observation from the data in the bilateral reconstruction category, was that 
their body fat and waist circurnference values were smaller compared to the R 
patients. This may have been attributable to the type of surgical intervention that 
sorne ofthe patients may have undergone as part oftheir reconstruction surgery. They 
may have had a surgical technique known as a TRAM, where part of the adipose 
tissue in the abdominal region, along with a small portion of the rectus abdominus 
muscle is transplanted into the chest wall to replace the breast, which may have 
accounted for the lower body fat and waist circurnference values seen this category 
(Christensen et al 2013). We did not k:now what type of reconstruction the patients 
underwent. 
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Why are women who undergo a full mastectomy more likely to have negative 
outcome measures compared to those undergoing a partial mastectomy? One 
explanation for the difference in body composition and blood pressure values for the 
partial mastectomy category may be related to the women' s ability to exercise at a 
higher intensity for change in their body' s metabolism (Demark-Wahnefried et al 
2001). It was expected that patients undergoing a full mastectomy would experience 
more restrictions in the upper bodysuch as tightness in the chest wall and upper arm 
region. With the removal of the breast, the fascia which envelopes the muscles in the 
region, become adherent to the torso. This adherence, if not addressed, will restrict 
shoulder mobility. When someone has a shoulder problem, dynamic movement of 
the upper and lower body may be altered. This change in movement pattern may 
make it uncomfortable for the patient to run, to walk briskly or exercise (Hojan et al 
2012). Alhough patients are encouraged to exercise a:fter surgery, many may not be 
receiving sufficient direction or encouragement to address sorne ofthese restrictions. 
It is not unreasonable to assume that the patients may become discouraged when they 
do not see sufficient progress from their efforts and ultimately stop exercising (Roneo 
et al2012).We do not know what the activity or fitness levels were of the patients that 
were tested. 
Patients were stratified into four age groups and type of surgery (see Tables 5.2to 
5.4). The same pattern that was seen in all patients (Table 5.1) was also seen in the 
40-49 age group (Table 5.2) and the 50-59 age group (Table 5.3) for cancer survivors 
(CS) who underwent a partial mastectomy or full mastectomy. The women in the 
older age groups, 60-69 yearsand 70-79 years (Tables 5.4 and 5.5) showed the same 
trends but the differences were not statistically significant between surgery categories 
and the regular (R)patient group. In sorne instances there was little difference 
between the women in the full mastectomy category and the unilateral reconstruction 
category. There seems to be no difference in blood pressure, heart rate, lean muscle 
mass or total body water values for women in the over 60 age groups compared to 
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the R patients. Percent body fat and waist circumferences remained higher forCS 
than for the R patients. 
There were only 6 patients in total in the age groups below 40 years of age. Their 
blood pressure and body composition values were poorer when compared to the R 
patients, but with the small number in these groups it was difficult to draw 
substantive conclusions. It was not apparent why the most significant impact of the 
different surgeries on women was in the the 40-59 and 50-59 age groups. It would 
appear that the older patients seemed better able to adapt to the intervention. 
One of the limitations of this study is that we did not know when the women 
underwent surgery though we did know that all of the women were at least one year 
post surgery. It is possible that the women in the older age groups may have had 
surgery a number of years previous and that their bodies gradually returned to what 
would be considered normal state. 
One observation that did stand out when we reviewed the BMI data for the 40-49, 50-
59 and 60-69 age groups, is that there was little difference between the groups i.e CS 
& R patients. If physicians were using BMI and body weight to help evaluate their 
patient' s health they may have been misled into thinking that their CS did not differ 
significantly from their R patients. Our data clearly shows that this was not the case. 
In a number of instances, BMI and body weight was very sirnilar. 
We evaluated effect size for all groups collectively and then grouped them by age. 
Effect size for all patients grouped by surgery ranged from small to medium (0.29-
0.60) effect. The effect size was more apparent when the surgery groups were 
strati:fied by age with the effect size varying from medium to large (0.37, 0.55, 0.61 , 
and 0.82) for diastolic blood pressure (age 40-49) for patients who had undergone 
partial mastectomy, full mastectomy, full bilateral mastectomy and unilateral 
reconstruction. With regard to body fat, the effect size stayed in the medium range 
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(0.30, 0.51, and 0.51) for the age 40-49 patients who had undergone partial 
mastectomy, full mastectomy and unilateral reconstruction. 
It is generally recognized that being physically fit is more important than being 
overweight (Blair et al 2012). We noted that the women studied were not only 
overweight but also had elevated blood pressure values. As well, these patients 
tended to have larger waist circumferences leading to the belief that the elevated body 
fat was more visceral fat. We would expect that these factors would place this group 
at a greater risk for cardiovascular disease. 
Sorne of the limitations of this study were the lack of information regarding fitness 
and activity levels, and health issue traits su ch as diet and to bacco use. As the Centre 
evolves we hope to be able to obtain this information, which will help us to better 
advise these women.Ideally we should have pre-surgery measures for this group, 
which would allow us to track and evaluate these individuals before and after each 
intervention with subsequent follow up. 
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Table 5.1: Ail patients stratified by type of surgery 
Outcome Regular Partial Full Bilateral Unilateral Bilateral 
Measurc Patient Mastectomy Mastcctomy Surgery Reconstruction Reconstruction F-Value 
n=3694 n=534 n=89 n=14 n=70 n=S 
Age (years) 54.61 60.16 59.15 62.57 56.00 57.00 39.71 
SD 9.41 8.85 9.22 8.9 7.68 13.1 
Weight (kg) 67.98 68.96 69.74 68.44 70.93 67.68 1.29 
SD 13.87 12.74 16.28 9.13 11.19 17.01 
BP Diastolic (mmHg) 74.18 75 .87* 77.52* 75.21 79.14* 73 .60 7.82 
SD 9.66 9.85 10.67 9.23 10.68 8.44 
BP Systolic (mmHg) 123 .48 128.06* 132.58* 128.17 120.80 14.21 
SD 15.83 16.91 17.39 15.72 14.87 22.13 
MAP(mmHg) 90.10 92.92* 94.90* 94.45 95.49* 89.33 9.14 
SD 12.59 12.35 15.16 10.69 11 .06 12.07 
Heart Rate (BPM) 73 .04 75.15* 78.02* 74.00 75 .36 64.20 6.29 
SD 12.02 12.80 13.72 12.31 14.55 9.39 
BMl 26.07 27.05* 27.12 26.75 26.82 4.11 
SD 5.16 4.93 5.81 3.72 4.81 6.91 
Muscle Mass (kg) 11.63 11.26* 11.09* 11.28 11 .87 10.57 7.32 
SD 1.59 1.40 1.50 0.87 1.35 2.29 
Total Body Water (kg) 31.90 31.01* 30 .50* 31.32 32.64 29.26 6.22 
SD 4.23 4.01 3.92 2.44 3.66 5.49 
Body Fat(%) 34.45 37.13* 38.09* 36.91 30.03 13.07 
SD 8.28 7.78 7.15 6.38 7.31 8.24 
Waist Circumf (cm) 84.91 87.61 * 87.66* 87.79 87.06 82.20 6.06 
SD 11.79 12.28 13 .03 8.83 10.77 11.82 
• Sign ificantal P<O. 05; SD, Standard deviation 
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Table 5.2: Patients aged 40-49 strati:fied by type of surgery 
Out come Rcgular Partial Full Bilateral Unilateral Bilateral 
Measure Patient Mastectomy Mastectomy Surgery Reconstruction Reconstruction F-Value 
n=985 n=62 n=18 n=2 n= l4 n=2 
Weight (kg) 67.48 67.88 69.31 67.55 71.32 59.00 0.40 
SD 14.72 13.47 12.92 10.25 13 .98 5.37 
BP Diastolic (mmHg) 73 .28 76.85* 78.56 67.50 81.07* 71.50 4.47* 
SD 9.52 9.16 10.61 6.36 15.09 3.54 
BP Systolic (mmHg) 118.45 121.00 126.22 126.43 104.01 2.75* 
SD 13.70 15 .95 15.62 13.44 20.17 0.71 
MAP(mmHg) 87.80 91.57* 94.44 83 .17 96.19* 85.50 3.51* 
SD 12.14 10.68 11.63 8.72 16.33 2.12 
Heart Rate (BPM) 73 .55 77.08 80.17 83 .00 76.21 59.00 2.74* 
SD 12.22 12.98 16.73 32.53 19.67 9.90 
BMI 25.33 25.71 26.42 26.84 21.80 0.66 
SD 5.10 4.99 4.31 2.19 5.83 2.69 
Muscle Mass (kg) 12.04 11.67 11.55 11.93 12.24 11.61 0.89 
SD 1.69 1.43 1.40 1.09 1.43 1.99 
Total Body Water (kg) 32.95 31.99 31.74 32.82 33 .48 32.18 0.83 
SD 4.43 3.88 3.78 2.40 3.91 5.36 
Body Fat(%) 31.73 34.16 35.95 35 .95 25.85 2.63* 
SD 8.20 8.42 5.73 4.95 8.96 5.73 
Waist Circumf (cm) 82.85 85.14 84.19 83 .00 84.71 73 .00 0.87 
SD 11.44 12.48 10.68 8.49 10.66 2.83 
*Significantat P<0.05; SD, Standard deviation 
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Table 5.3: Patients aged 50-59 strati:fied by type ofsurgery 
Outcome Regular Partial Full Bilateral Unilateral 
Measure Patient Mastectomy Mastectomy Surgery Reconstruction F-Value 
n=1447 n=l78 n=24 n=2 n=35 
Weight (kg) 68.44 68 .97 74.07 72.05 71.59 1.41 
SD 14.18 11.60 22.79 0.78 11.19 
BP Diastolic (mmHg) 75.02 76.69 80.50* 73 .50 79.94* 4.93* 
SD 9.64 10.05 9.99 2.12 10.16 
BP Systolic (mmHg) 122.96 124.79 132.54* 128.00 4.31 * 
SD 15.72 15 .81 17.70 4.95 14.60 
MAP(mmHg) 90.44 92.20 97.85* 97.17 95.96* 4.21 * 
SD 12.81 13 .06 11.10 3.06 10.75 
Heart Rate (BPM) 73 .20 76.02* 78.42 65.50 76.11 3.60* 
SD 12.09 13.51 13 .12 7.78 14.44 
BMI 26.18 26.67 27.70 26.48 0.96 
SD 5.17 4.32 8.18 0.71 4.57 
Muscle Mass (kg) 11.68 11.49 11.54 11.39 12.00 1.06 
SD 1.55 1.36 1.74 0.38 1.32 
Total Body Water (kg) 31.99 31.47 32.00 31.71 33 .02 1.13 
SD 4.26 4.28 5.16 0.71 3.59 
Body Fat(%) 34.81 36.12 38.92 40.15 36.22 2.70* 
SD 8.28 7.37 8.74 1.06 6.97 
Waist Circumf (cm) 85.12 86.70 89.38 95.00 87.84 2.lJ Y 
SD 11.95 10.64 16.38 5.66 11.00 
*Significantal P<0.05; SD, Standard deviation 
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Table 5.4: Patients aged 60-69 strati:fied by type ofsurgery 
Outcome Regular Partial Full Bilateral Unilateral Bilateral 
Measure Patient Mastectomy Mastcctomy Surgery Reconstruction Reconstruction F-Value 
n=879 n=207 n=30 n=6 n=17 n=3 
Weight (kg) 68.87 68.60 69.68 66.42 67.82 73.47 0.18 
SD 12.97 13 .18 14.40 12.97 8.63 20.94 
BP Diastolic (mmHg) 74.66 71.11 77.28 77.00 77.29 75.00 1.35 
SD 9.55 9.49 10.59 10.51 8.11 11.36 
BP Systolic (mmHg) 128.81 131.36 132.48 128.82 131.67 1.25 
SD 15.89 15.72 17.87 17.34 10.81 23.16 
MAP(mmHg) 92.19 94.53 92.49 96.28 94.47 93 .89 1.35 
SD 12.68 10.53 20.82 11.91 7.60 14.54 
Heart Rate (BPM) 72.65 75.07* 77.72 74.33 74.65 67.67 2.41* 
SD 11.75 12.86 12.72 9.35 10.52 9.07 
BMl 27.00 27.17 27.62 25.91 30.17 0.62 
SD 5.07 4.97 5.30 4.88 3.35 7.05 
Muscle Mass (kg) 11.27 11.02 10.96 11.23 11.30 8.48 1.97 
SD 1.39 1.39 1.40 .99 1.29 0.0()€ 
Total Body Water (kg) 31.07 30.47 29.77 31.24 31.21 23 .41 2.17* 
SD 3.72 3.83 2.32 2.96 3.58 0.0()€ 
Body Fat(%) 37.06 38.00 38 .40 38.02 38.40 0.77 
SD 7.41 7.42 6.50 5.55 5.71 O.OCJ€ 
Waist Circumf (cm) 87.30 87.33 89.37 82.42 84.76 88.33 0 .. 62 
SD 11.50 13 .80 12.73 8.65 7.85 11.59 
*Significantat P<0.05; SD, Standard deviation 
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Table 5.5 : Patients aged 70-79 strati:fied by type ofsurgery 
Outcome R cgula r P a rtial F uJI Bila t eral Unila ter a l 
Measure 
P a tient Mastectom y Mastectomy Surgery R econs truction F-Value 
n= 223 n=78 n= 17 n=4 n=3 
Weight (kg) 66.37 70.31 64.21 70.10 77.43 2.233 
SD 12.55 13.26 9.91 4.98 12.75 
BP Diastolic (mmHg) 72.47 72.82 72.65 77.25 71.00 .239 
SD 10.16 10.65 10.94 11.00 2.65 
BP Systolic (mmHg) 132.93 132.67 139.53 138.33 .680 
SD 15.89 15.72 17.87 17.34 10.81 
MAP(mmHg) 92.21 91.60 94.94 96.00 93.45 .312 
SD 12.30 15.97 11.60 11.44 5.40 
Heart Rate (BPM) 70.90 71.87 75 .71 73 .25 62.33 1.181 
SD 12.16 10.67 11.54 5.91 3.06 
BMI 26.56 28.51* 26.22 33 .53 3.262* 
SD 5.27 5.60 4.24 2.43 7.25 
Muscle Mass (kg) 10.67 10.91 10.13 10.95 10.39€ 1.459 
SD 1.22 1.25 .91 .87 0.00 
Total Body Water (kg) 29.52 30.32 28.07 30.49 29.30€ 1.717 
SD 3.34 3.49 2.57 2.56 0.00 
Body Fat(%) 37.23 39.84 38.54 51.10€ 2.220 
SD 7.90 8.01 7.16 8.83 0.00 
Waist Circumf (cm) 87.10 90.86* 85.88 94.63 103.00 3.225* 
SD 11.36 12.85 9.21 2.93 15.39 
*Significantat P<0.05; SD, Standard deviation 
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This abstract was submitted to the 2013 CanadianSociety of Exercise Physiologist 
(CSEP) Conferenceheld in Toronto, Canada, October 16- 19 2013. 
6.1 Overview of the fourth manu script 
Key points 
We believe that a significant number of women preparing for breast surgery already 
have sorne underlying shoulder problems. These underlying problems make it difficult 
for the patient to differentiatebetween what was present before surgery and what signs 
and symptoms are present after surgery. 
Main fmdings 
Almost one third of ail patientstested had positive impingement and/or thoracic outlet 
type problems. No matter what type ofbreast surgery these patients had,their shoulder 
mo bility was further comprised. 
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Women waiting to undergo breast surgery to remove a turnour often experience 
transient shoulder limitations after surgery. These limitations can be further 
aggravated if the women have a pre-existing shoulder problem. The purpose of this 
study was to determine how many of the women waiting for surgery had positive 
shoulder impingement signs and positive thoracic outlet signs, both of which may 
pralong rehabilitation. 
As part of a pre-surgery education process for the women at VM Medical, a number 
of objective outcome measures were performed to identify women who might be at 
risk for developing shoulder problems post-surgery. Of the 102 women who were 
evaluated before surgery, 42 out of 82 women had a positive Neer test, 33 out of 87 
had a positive Hawkins Kennedy test, and 31 out of 85 had a positive Roos test. A 
significant correlation (p=0.01) was found between positive impingement tests and 
positive thoracic outlet tests. As expected shoulder range of motion was decreased 
a:fter surgery especially in those women who underwent a full mastectomy. Women 
with higher Body Mass Index (BMI) scores were also more likely to have positive 
tests. This information should be taken into consideration when advising women 
about what to expect post-surgery and to differentiate between previous shoulder 
problems and potential shoulder problems related to their irnpending surgery. 
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Introduction 
After surgery to remove a suspicious lump in the breast, it is not uncommon for 
women to experience an initialloss in their shoulder mobility, a reduction in forearm 
strength, and adherence of the subcutaneous fascia to muscle, restricting arm mobility 
(Levy et al2012). With appropriate direction many ofthese women are able to regain 
their shoulder mobility and strength with few problems (Levy et al2012). Delay in or 
lack of immediate postoperative exercise may result in adverse outcomes such as 
spasm of the musculature surrounding the joint, muscle atrophy, tightening of the 
shoulder capsule, and decreased short- and long-term functional mobility, increasing 
the risk of chronic irnmobility and pain (Hauglann et al2012). 
If a patient currently has a shoulder/arm problem that is painful or is predisposed to 
shoulder dysfunction, it is not unreasonable to expect that this patient may have 
difficulty distinguishing between what was there before breast surgery and what the 
limitations are as a result oftheir surgery. Understanding the difference between the 
two problems should make it easier to outline realistic goals for the patient so that the 
patient does not become discouraged (Herrera and Stubblefield, 2004). 
It is unclear how many women who begin adjuvant therapy associated with breast 
cancer are dealing with musculoskeletal restrictions in the upper body. We do know 
that many women are at risk of developing musculoskeletal pain in the upper body, 
particularly in the neck and shoulder regions (Lindegârd et al 2012). It would be 
expected that any pain a woman was experiencing in the neck and shoulder regions 
prier to surgery would have a lower priority once a lump in the breast has been 
discovered and surgery is recommended. 
Women in general seem to be at greater risk for developing pain in the neck, shoulder 
and arm regions in comparison to men because they engage in more occupations that 
expose them to upper body injuries (Sorock GS and Courtney 1996). The increased 
risk may be associated with work environments that require the women to perform 
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repetitive movements over prolonged periods oftime, such as working at a computer. 
This environment places them at greater risk of developing chronic musculoskeletal 
dysfunction and possible neurological problems(Howard M, Lee and Dellon 2003 ). 
The goal of this study was to evaluate how many women were already at risk of 
developing upper body dysfunction before undergoing breast surgery. Our team 
believed that a number of women were at risk of developing problems in the upper 
body and that the start of breast cancer treatment increased their risk of dysfunction 
taking place. Understanding this risk and incorporating preventative strategies could 
help these women better tolerate the treatment protocols. 
Methods 
As part of the standard intake evaluation, patients waiting for their annual 
marnmogram met with one of the physicians at VM Medical and underwent a series 
of tests adrninistered by one of the kinesiologists working at the Centre. Each patient 
who visited VM Medical was asked to review and consider signing a consent form 
that allowed for their medical information to be entered into VM Med's medical 
records database.These medical records are used by the medical team to help monitor 
and assess patient needs. 
Test results were entered into the database. The information that was extracted from 
the database and that was used for this study, had personal information removed so 
that no individual could be identified. The study was approved by the VM Medical 
Ethics Board and conforrned to the World Medical Association (WMA) Declaration of 
Helsinki, Ethical Princip les for Medical Research Involving Human Subjects. 
Patients who were scheduled for breast surgery were asked to undergo a preoperative 
evaluation by the Kinesiology team. The preoperative session had five main 
components which included; 1) Outlining to the patient what she could expect post-
operatively; 2) Reiterating the surgeon's preoperative instructions; 3) Outlining the 
----------
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post-operative exercises that needed to be performed; 4) Performing base line testing 
of patients, including shoulder mobility, arm strength, present activity level, body 
composition, shoulder impingement, as weil as, testing to evaluate neurovascular 
occlusion; and 5) Addressing additional questions that the patient had concerning 
treatment. 
Kinesiologists met with each patient for approximately 90 minutes. Recognizing the 
amount of stress that the patient was under, given the recent diagnosis of a suspicious 
lump in their breast, it was left to the discretion of the kinesiologist working in 
consultation with the patient to determine what information and testing was most 
important for the patient at that particular stage. 
A series of tests were performed before surgery, to evaluate the patient's shoulder 
range of motion, forearm strength, and the presence of shoulder pain or upper 
extremity circulation issues. The breast surgery was either a partial or full 
mastectomy with either sentinel node or axillary node sampling. 
Before surgery, the women were asked to undergo testing to evaluate their current 
level of shoulder function and their current level of physical activity. The testing 
session was also used by the kinesiologists to advise the women on the appropriate 
exercises to be performed postoperatively. The testing session also provided an 
opportunity for women to ask any questions they had concerning potential 
postoperative problems. Again, recognizing the amount of stress that the patient was 
under with a recent diagnosis of a suspicious lump in their breast, it was left to the 
discretion of the kinesiologists working in consultation with the patient to determine 
what information and testing was most important for the patient at this stage. The 
following tests were performed; 
Shoulder flexion 
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Shoulder flexion was assessed with the use of a handheld goniometer. The subject 
was assessed in a standing position, with the axis of the goniometer positioned at the 
acromion process of the scapula, through the head of the humerus. The stationary 
arm of the goniometer was placed along the mid axillary line of the trunk, while the 
moving arm was placed along the midline of the humerus in line with the lateral 
epicondyle. 
Forearm strength 
A Jamar hand grip dynamometer (Lafayette Instruments, Lafayette, IN USA) was used 
to assess forearm strength. The adjustable handle was fit to the hand size of the 
patient so that the proximal interphalangeal (PIP) joints of digits 2 through 5 were 
positioned at a 90degree angle of finger flexion as a starting position. The subject 
kept their shoulder in a neutra} position and their elbow extended by their side while 
performing the test. The subject squeezed the dynamometer with maximum isometric 
effort, and maintained the effort for 5 seconds. 
Shoulder dysfonction 
Shoulder irnpingement was assessed with the use of the Neer test and the Hawkins 
Kennedy test. With the Neer test(Palmer and Epier 1998), the patient' s arm was 
moved into end range of flexion at the same tirne as the patient's scapula was 
stabilized. The test was considered positive if it elicited pain, typically at the end of 
the range of flexion. If the patient had full shoulder flexion with overpressure applied 
at the end of the range, withoutexperiencing pain, then the test was considered 
negative. 
The Hawkins Kennedy test(Palmer and Epier 1998) was performed by flexing the 
elbow to 90 degrees and then elevating the patient's arm to 90 degrees of shoulder 
flexion and then internally rotating the shoulder. The patient either experienced pain 
with this manoeuvre or tried to elevate the ipsilateral shoulder to increase the 
subacromial space and prevent the irnpingement. 
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When pain occurred with either of these tests, it was considered a positive sign for 
sub-acromial impingement0. The goal behind these tests was to transiently aggravate 
inflamed or impinged structures as they passed under the coracoacromial arch. The 
inflamed structures may have included the long head of biceps tendon, the 
supraspinatus tendon and/or sub acromial bursa. 
Thoracic outlet test-Roos test 
Testing was performed to assess for the possibility of neurovascular occlusion often 
associated with thoracic outlet syndrome through the use of the Roos Test (Howard, 
Lee and Dell 2003). The patients were asked to abduct bath shoulders to 90 degrees 
and then flex bath of the ir elbows to 90 degrees. They were then asked to open and 
close the ir hands repeatedly for up to 3 minutes. During that time if the patient started 
to experience numbness and/or a pins and needles sensation in their hands, the test 
was stopped and a positive sign noted. Ifthere was no presence ofnumbness and/or a 
pins and needles sensation, then a negative sign was recorded. 
Lev el of activity 
To gain an understanding of the patient's typical level of physical activity, patients 
were asked to indicate what best represented their current level of activity. The scale 
was: 1) Active 1 day per week; 2) Active 3-5 days a week; and3) Active every day of 
the week. 
BMI (Body Mass Index) 
Patient's height and weight were recorded and were classified according to BMI 
based on the Canadian Physical Activity, Fitness and Lifestyle Approach (CP AFLA-
CSEP). Patients were ranked as follows;Mild thinness (BMI 17.0 -18.49), 
Normal (BMI 18.0- 24.9), Pre-obese (BMI 25.0- 29.9), Obese level I (BMI 30.0-
34.9), Obese level II (BMI 35.0- 39.9), Obese level III (BMI greater than 40.0). 
Data analysis 
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Statistical analysis was performed using IBM SPSS version19.0. A one-way nova 
with Tukey post-hoc analysis was performed on shoulder ROM (range of motion) 
measures with significance assumed at P<0.05. 
Simple t-tests were performed on handgrip strength measures. Significance was 
assumed at P< 0.05 . Pearson correlation was used to evaluate relationships between 
outcomes measures. Significance was assumed at P< 0.05 . 
Results 
From a total of224 VM Medical patient visits, 156 were seen in the WC.Ofthese 156 
patients, 84 patients were evaluated preoperatively only, 41 patients were evaluated 
postoperatively only, and 31 patients were evaluated preoperatively and post-
operatively. A total of 94 patients had a partial mastectomy; 45 had a full 
mastectomy; and 10 had bilateral full mastectomies. The type of surgery was not 
recorded for 7 of the patients. 
Hand dominance 
A total of 146 patients were right-handed and 8 patients were le:ft-handed. Two of the 
patients' hand dominance was not recorded. For 81 patients, the primary surgery was 
performed on the right side; 75ofthe patients had surgery on their le:ft side. 
Preoperative shoulder impingement 
The Neer test was administered to82 patients,42 ofwhom had positive findings, while 
40 had negative fmdings, provoking pain. The Hawkins-Kennedy test was performed 
on 87 patients, 33 of whom bad positive fmdings while 54 had negative findings, 
provo king pain.(Table 6.1 ). 
Preoperative potential thoracic outlet problems 
The Roos test was performed on 85 patients; 31 tests were positive and 54 tests were 
negative for signs ofnumbness or a tingling, pins and needles sensation (Table 6.1). 
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Shoulder flexion (ROM - Range of Motion) 
Pre-surgery shoulder flexion tests showed little variation between groups (partial 
mastectomy; full mastectomy) for either the left or right arm, with values ranging 
:from173-176 degrees. Postoperatively, there was a significant difference between 
groups with patients who underwent a full mastectomy having poorer shoulder 
flexion with values varying from 115-119degrees. Patients who underwent a partial 
mastectomy had the greatest shoulder flexion with values varying :from139-146 
degrees. (Table 6.2). 
Grip strength 
Grip strength tests were only performed pre-surgery and not post-surgery. The mean 
grip strength on the left side was 23 .05 with SD of 4.85 while mean grip strength on 
the right side was 24.69 with SD of 5.30, total grip strength 46.91 with a SD of 9. 76. 
A simple test showed a significant difference (p<0.001) between left and right hand. 
(Table 6.2). 
Pearson correlation (with signi:ficance set at 0.05, 2 tailed) showed a significant 
correlation with a positive Neer ' s test and a positive Hawkins-Kennedy test (P<0.05, 
r2= 0.59) and positive thoracic outlet test (p<0.05, r2= 0.71). 
Correlation between shoulder ROM, grip strength and positive tests 
A significant correlation was found between the Hawkins-Kennedy impingement test 
and the postoperative shoulder flexion on the left side (p=0.28, r=0.31). Correlations 
were also seen between handgrip strength on the left and pre-surgery shoulder flexion 
on the left (P<0.05, r2=0.12) and on the right (P<0.05, r2=0.09) (Tables 6.1 and 6.2). 
No differences between groups, however, were observed (Tables 6.3 and 6.4). 
BMI (Body Mass Index) 
The weight and height of 77 patients were taken and recorded. The BMI for 41 of 
these patients was within the normal range, while 15 patients were consideredpre-
- ----------------- -----
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obese/overweight and 19 were considered obese. Only 2 patients fell within the "mild 
thinness" category. (Table 6.6) 
Fitness level 
Patients were asked to identify their typical activity level during a regular week: 
There were 28 patients who did light exercise on a regular basis, one time per week 
(Level 1). There were 37 patients who did light exercise on a regular basis, three 
times per week (Level2). There were 49 patients who did regular, moderate-intensity 
exercise three to five times per week (Level 3). There were 10 patients who did 
regular exercise every day ofthe week (Level4). Finally, there were 10 patients who 
did not exercise on a regular basis(Table 6.5). A total of 97 patients were not askedor 
did not identify their level of acti,vity 
Discussion 
The purpose of this study was to implement a preoperative protocol for women 
waiting to undergo breast surgery. This protocol would provideinformation such as 
the functional capacity and activity level of the women before their surgery. This 
information in turn could be used to advise the women on what they should do to 
minimize the potential negative effects associated with surgeryand also help to 
identify patients who may be at greater risk for post-operative problems. 
It was expected, based on a literature review, that 15-20% ofthe women would have 
positive impingement tests; however, it was surprising to see that 38% ofthe patients 
had positive tests. There was a correlation between a positive Hawkins-Kennedy test 
and reduced shoulder range of motion on the left side after surgery (Kappe et al 
2013). Bath the Hawkins Kennedy and the Neer tests assessed the presence of 
impingement in the anterior aspect of the shoulder. This was not the only type of 
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shoulder problem that a patient would hav experienced, but it was one of the more 
common pathologies. 
The expectation was that the women who did have positive tests before surgery 
would continue to have positive tests after surgery. We also expected that certain 
regions would show greater sensitivity before and after surgery in patients with 
positive tests. 
Previous studies have recognized that dysfunction can occur after breast surgery 
(Dahl et al 2011, McNeely et al 2010). These studies evaluated patients 
postoperatively usrng impingement tests. Studies that evaluated patients 
preoperatively focussed on range of motion testing and in sorne instances didso 
repeatedly; however,they did not include preoperative impingement testing. 
At the WC the time frame between diagnosis of a lump in the breast, repeated 
imaging, and follow up consultation leading to surgery was approximately 10 days. 
Due to the small window of time from diagnosis to scheduling of surgery, it was 
often difficult to obtain preoperative information on all patients. The preoperative 
evaluation combined withthe surgery and the surgical frndings are important pieces of 
information which helpto direct the patient asto the appropriate type oftreatment and 
the recommended follow-up. 
Patients who had a higher BMI score were shawn to be more likely to have positive 
impingement tests and positive thoracic outlet tests. This is consistent with a study by 
Nilsen et al2011 who showed that women who had higher BMI scores were more 
likely to have shoulder/neck and lower back problems compared to women with 
lower BMI scores. (Table 6.6). 
There was a signi:ficant correlation between higher total handgrip values and higher 
fitness level scores. There was also a signi:ficant correlation between higher hand grip 
scores and pre-operative shoulder range of motion values. Post-operative handgrip 
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values were not collected because of concernsthe Centre's physicians had about the 
effects of maximal exertion of the forearm muscles two weeks a:fter surgery. 
By far the vast majority of the patients were right-hand dominant, which would 
account for the difference in grip strength between the left (23.05±4.85) and right 
hands (24.69± 5.30). When looking at hand grip strength both groups would be 
ranked below average when compared to the normative values for handgrip strength. 
There was a trend between the type of surgery that was performed and the likelihood 
of reduced shoulder range of motion after surgery. Patients that had a bilateral 
mastectomy or a full mastectomy had reduced post-operative range of motion 
compared to patients who had a partial mastectomy. 
Factors have come to lightthat may help identify patients at risk of developing post-
operative problems. Certainly a risk of pre-existing problems may be considered a 
factor as well as the patient's body composition and the type of breast surgery.A 
patient at lower risk would be a patient that has negative impingement or thoracic 
outlet tests, a lower BMI, and undergoing a partial mastectomy. A patient at greater 
risk would be a patient with positive impingement or thoracic outlet tests, a high BMI 
score, possibly less physically active, and undergoing a full mastectomy. Previous 
studies have also shown that the removal of multiple lymph nodes may also be a 
factor in the patient's recovery. 
One of the limiting aspects of this study was the postoperative follow up of all the 
patients. Patients that were doing well after surgery did not feel the need to come in 
for post-operative follow up at the WC. They wanted to get themselves ready in 
anticipation for the recommended adjuvant therapy. This is a step that bas been do ne 
in other studies often without the inclusion of the pre-surgery measures (Stan et al 
2012, Chan, Lui and So 2010). 
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It was important to implement the pre-operative protocol with an understanding of the 
amount of stress the patients are under while waiting for surgery combined with the 
possibilityadjuvant therapy after surgery.The next step in this preoperative 
assessment protocol would be to evaluate pain objectively before and after surgery. 
On a number of occasions pam has been evaluated subjectively v1a 
questionnaires,often in conjunction with shoulder mobility testing. 
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Table 6.1: Impingement and thoracic outlet testing 
N Neer test % HK % Roos- test % 
Total 82 87 85 
Positive 42 51.22 33 37.93 31 36.47 
Negative 40 48.78 54 62.07 54 63.53 
Tab 
Hawkins - Kennedy lmpingementtest (HK) le 
6.2: 
Patients stratified according to surgical intervention 
Partial N Full N Bilateral Mastectomy Mastectomy Mastectomy 
Grip Strength Left 63 23.48 21 22.79 5 20.40 
SD 4.84 4.90 4.34 
Grip Strength Right 64 25.50 21 22.95 5 22.60 
SD 5.34 5.21 4.10 
Grip Strength Total 63 47.95 21 45.26 5 43.00 
SD 9.94 9.71 7.48 
Pre-surgery Left ROM 73 174.41 22 175.95 6 173.33 
SD 11.49 7.69 7.53 
Pre-surgery Right ROM 72 174.29 2~ 173.13 5 173.40 
SD 11.77 15.78 7.60 
Post-surgery Left ROM 27 145.52 16 119.00 6 129.33 
SD 33 .19 34.18 25.19 
Post-surgery Right ROM 28 138.68 14 114.86 6 126.17 
SD 40.33 39.61 21.91 
- -------------
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Table 6.3: Analysis ofvariance (ANOVA)of pre-surgery and post-surgery measures 
df Mean Square F Sig. 
Pre-surgery Left ROM Between Groups 3 26.631 .237 .871 
Within Groups 98 112.591 
Total 101 
Pre-surgery Right ROM Between Groups 3 8.426 .053 .984 
Within Groups 98 159.313 
Total 101 
Postsu rgeryl Left ROM Between Groups 3 2499.769 2.330 .087 
Within Groups 46 1072.784 
Total 49 
Postsurgeryl Right ROM Between Groups 3 2320.108 1.565 .211 
Within Groups 45 1482.548 
Total 48 
P<0.05 
Table 6.4: Post-hoc analysis of shoulder flexion after surgery 
Type of Surgery n 1 2 
Full Mastectomy 10 102.00 
Bi lateral Mastectomy 19 136.68 136.68 
Partial Mastectomy 2 150.00 
Sig. 0.192 0.773 
Tukey post hoc test P < O. 05 
Table 6.5: Perceived activity level of patients 
Val id Leve! 1 (Occasional exercise, once a week) 
Leve! 2 (Regular light exercise, 3 days/week) 
Leve! 3 (Regular moderate exercise, 3-5 days a week) 
Leve14 (Very active regular exercise, every day) 
Sedentary (No regular exercise) 
Total 
Table 6.6: Body Mass Index (BMI) of patients 
Valid Mild Thinness (17.0- 18.49) 
Normal Range (18.50 - 24.99) 
Pre-Obese 1 Overweight (25.0 - 29.99) 
Obese Class 1 (30.0 - 34.99) 
Obese Class II (35.0- 39.99) 
Obese Class rn (2: 40.0) 
Total 
Frequency 
28 
37 
49 
10 
10 
134 
Frequency 
2 
41 
15 
12 
4 
3 
77 
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CHAPTER VII 
RESULTS PERTAINING TO ADDITIONAL QUESTIONS 
7.1 Question l:Relationship between hormone therapy and body composition 
The following information concerning the relationship between hormone therapy and 
cardiovascular risk factors was presented at the 2013Groupe de Recherche en 
ActivitéPhysique Adaptée (GRAP A) International Conference held in Montréal, 
Canada. It was presented in the poster section of the conference and is titled:Impact of 
different estrogen inhibitor therapy on body composition and vital sign measurements 
in breast cancer survivors. Below is the abstract of the poster presentation, followed by 
Table7.1 outlining the datathat is presented. 
Abstract 
Purpose 
The purpose of the study was to determine if body composition and basic 
cardiovascular function of cancer survivors varies depending on the type of hormone 
therapy being given to women as part of adjuvant therapy. 
Methods 
Kinesiologists performed base line measurements on 3,673 regular (R) patients and 716 
cancer survivors. The cancer survivors were stratified into 5 different groups according 
to type of hormone therapy as follows; Arimedex (A) = 97 patients, Aromasin (Ar) = 
14 patients, Tamoxifen (T) = 143 patients, no hormone therapy (N) = 191 patients and 
those who had completed hormone therapy (C) = 271 patients. These groups were then 
compared to the R patients. A one way ANOVA was performed followed by Dunnett's 
post hoc analysis withsignificance set at p < 0.05. 
-----------------------------------------
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Results 
Across ali groups mean age(± SD) was 55.4 yrs±9.29; height was 160.9 cm±7.60; and 
weight was 68.19 kg±13. 7 5. Significant differences were se en between the cancer 
survivors in ail groups and the regular patients with p<0.001 in 6 key variables as 
follows; diastolic blood pressure (F= 7.10) 11= 74.2 mmHg (R) vs 11= 78.3 mmHg (Ar); 
systolic blood pressure (F= 13.27) 11= 123.5 mmHg (R) vs 11= 129.9 mmHg (A); 
muscle mass (F= 5.88) 11= 11.6 kg (R) vs 11= 11.2 kg (C and N); total body water 
(F=4.64) 11= 31.9 kgs (R) vs 11= 30.9 kgs (C);% body fat (F=13.64) 11= 34.5 % (R) vs 
11= 38.3 %. (A); and waist circumference (F= 9.04) 11= 84.9 cm (R) vs 11= 93 .8 cm (Ar). 
Conclusion 
Different hormone therapy protocols for cancer survivors appear to increase 
cardiovascular risk factors associated to negative changes in body composition and 
blood pressure. 
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Table 7.1: Treatment of patient strati:fied according to type of hormone therapy 
Regular No Completed Arimedex Aromasin Tamoxifen hormone hormone F value Patients therapy therapy (Between 
N=3673 N=97 N=14 N=l43 N=191 N=271 
groups) 
Age (years) 54.61 60.29 65 .5 54.84 59.11 62.06 51.1 
SD 9.14 7.81 7.89 9.1 8.59 8.31 
Mean weight (kg) 67.98 70.85 71.86 68.58 69.7 68.55 1.61 
SD 13.87 12.26 9.77 13.39 14.54 12.02 
BP Diastolic (mmHG) 74.18 78.34 € 78.34 € 77.11 75 .66 76.17 7.13 
SD 9.66 8.85 16.67 10.17 9.92 10.08 
BP Systolic (mmHg) 123.48 129.87 € 126.79 127.61 127.9 129.55 13.31 
SD 15.83 15.87 34.92 17.73 16.42 15.65 
MAP(mmHg) 90.1 94.88 € 94.50 € 93.94 92.27 93.79 9.1 
SD 12.59 9.93 22.34 11.78 13.2 13.2 
Heart rate (BPM) 73 .04 77.11 € 74.04 77.09 75.83 73 .8 6.62 
SD 12.02 12.06 9.87 13.21 13 .95 12.56 
BMl 26.07 27.78 28.49 € 26.32 27.22 26.91 5.34 
SD 5.16 4.75 4.83 4.86 5.4 4.83 
Muscle mass (kg) 11.38 11.15 10.95 11.18 11.07* 10.92* 5.91 
SD 1.55 1.24 1.14 1.38 1.54 1.31 
Total body water (kg) 31.2 30.74 30.3 30.8 30.34* 30.16* 4.65 
SD 4.14 3.39 2.99 3.83 4.6 3.59 
Body fat(%) 34.45 38.34 € 37.84 € 35.88 37.28 € 37.39 € 13.63 
SD 8.28 6.51 8.4 7.97 7.87 9.85 
Waist Circumf (cm) 84.91 90.12 € 93 .75 € 85.08 88.14 87.22 9.06 
SD 11.79 11.12 11.21 11.01 11.77 13 .01 
* Jndicates that post hoc ana/ysis using the Dunnett 's test showed significant difference P<O. 05 
between regular patients (control) and patients thal had treatment fo r breasl cancer and were in a 
medication group. ê lndicates that measure for this group would be in the 62-69 percenti/e when 
compared to the control group and wou/d be considered a medium e.ffect size. 
7.2 Question 2: Fitness levels ofthe patients at VM Medical 
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The establishment of standard testing protocols by VM Medical's lntegrative Health 
and Wellness Centre (WC) andthe sharing ofthe information with the medical staffhas 
led tothe WC being recognized as an important contribution to addressing the health 
needs of both cancer survivors(CS) and the regular (R) patients. Building on the 
standardized intake evaluation enabled the WC to offer fitness evaluations to its patient 
population. To conduct fitness evaluations, the WC utilizes the protocol put forward by 
the Canadian Society for Exercise Physiology (CSEP). This protocol uses aged 
matched data to identify the level of fitness of the patient. The information obtained 
provides ready feedback to the patients. 
The data presented in Tables 7.2 and 7.3 below, show the results of CSEP fitness tests 
performedon regular (R) patients. Since November 2012, the testing protocol has been 
expanded to include CS as well. It is expected that by the FaU of2013,sufficient cancer 
survivors will have been tested so that aged matched analysis maybe performed. We 
believe thatthere will be a significant difference in body composition and blood 
pressure values between our 2 major groups of patients. Our expectation is that the CS 
are less likely to score as high on the fitness tests compared to the R patients. 
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Table 7.2: Fitness levels of women at the VM Medical Intregrative Health and 
Wellness Centre (WC) 
Back Partial HandGrip Partial Trunk Aerobic Fitness Levet Fonvard Fitness Extension Curt Up Strcngth Push Up flexion TrcadmiU 
Excellent 46 59 13 40 16 6 
Very good 31 27 28 50 19 3 
Good 27 37 22 26 21 29 
Fair 19 6 29 10 32 19 
Need irnprovement 7 28 51 3 43 58 
Not done 27 0 14 28 26 42 
Table 7.3: Mean values from the Canadian Physical Activity, Fitness and Lifestyle 
Approach (CP AFLA/CSEP) testing 
Mean Median 
Back Ext. Modified Total Sec. 105.86 101 
Back Ext. Total Sec. 87.75 74 
Grip Strength Left (k:glm) 22.8 22 
Grip Strength Right (k:glm) 24.84 25 
Grip Strength Total (kg/rn) 47.64 47 
Partial Curl-Ups Total Modified 18.9 20 
Partial Curl-Ups Total Standard 21.38 25 
Push-Ups Total Modified 17.62 19 
Push-Ups Total Standard 14.73 13 
Trunk Forward Flex. Standard Reach 26.89 27.25 
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Many of the women fall into "need improvement" category. When loo king at forearm 
strength, 51 were identified as in need of improvement for hand grip strength and 58 
need improvement in cardiovascular fitness (Bruce protocol). Many of the women 
scored from good to excellent in abdominal strength. 
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7.3 Question3:Use of the hand-held algometer and the Jones template 
The protocol to measure the pressure pain thresholds(PPT) of breast cancer 
patientsutilizing the Jones template is only just beginning at the VM Medical 
Integrative Health and Wellness Centre (WC). A handheld algometer is applied to eight 
different locations in the upper body before and after surgery. The locations where the 
algometer is applied follows the Jones template that was validated inD.H. Jones' 
masters thesis.It is expected that over the next two yearswewill reach the21 patients 
required to give the study su:fficient power to detect statistical signi:ficance. When 
patients are seen preoperatively and postoperatively it is not uncommon for many of 
them to have pain in their upper back and neck region. This includes the appearance of 
trigger point nodules in the upper trapezius and the rhomboid muscles. We expect the 
Jones template will yield sorne interesting results and will be a useful tool for 
clinicians, researchers and patients. 
Utilizing the algometer on one patient pre-surgery and post-surgery showed that the 
pre-surgery values at the eight different locations were similar to the values obtained in 
previous work by Jones, Kilgour and Comtois, 2008. The post surgery measures 
showed site specifie sensitivity in the supraspinatus and trapezius locations with lower 
PPT values. 
CHAPTER VIII 
SUMMARY AND FUTURE DIRECTION 
8.1 Summary of manuscripts 
In manuscripts 1 and 2, we foundsignificant differences across a number of outcome 
measures between the cancer survivors (CS) and the regular (R) patients. We also noted 
that,for cancer survivors, body fat is a better indicator of change in MAP values 
compared to a person's waist circumference. 
In manuscript 3 and the manuscript that has been included in Annex3, we observed that 
patients undergoing more extensive surgery and multiple forms of cancer treatment are 
at greater risk for developing cardiovascular problems, though it is not clear whether 
the women were already at greater risk before having any form oftreatment. It is also 
unclear to what extent surgery and cancertreatment are contributory factorsto the 
increase in risk of cardiovascular disease. 
Inmanuscript 4, we noted that a significant number of women were at risk for shoulder 
problems before undergoing breast surgery and depending on the the type surgery these 
women could alsoexpect to have a transient reduction in shoulder mobility a:fter 
surgery. 
8.2 Future Direction 
Theinformation presented in the five different manuscripts and the additional questions 
is only a very small portion of the activities performed at VM Medical. One of the most 
valuable tools of the Centre is the pre-surgery evaluation in which the women receive 
information as to what to expect with breast surgery and what they need to do a:fter 
surgery to minimize complications. This also includes the post-surgery followup where 
the women are able to make use of the WC exercise facility under the supervision of 
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the staff. These initiativeshave reduced the number of women who need to seek 
additional treatment for post-surgical complications, which in turn has reduced sorne of 
the women's stress and also provided them tools they can utilize as they go through 
treatment. 
There is a lot of work still to done for cancer survivors. We expect to continue our 
work with VM Medical patients in the hope that we can contribute to improving their 
quality of life as weil as help reduce their risk for cancer re-occurrence, cardiovascular 
disease, and other chronic diseases. 
VM:MED:~UQÀM 
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ANNEXA 
Faculté des sciences 
Université du Québec à Montréal 
FORMULAIRE DE CONSENTEMENT POUR PARTICIPER DANS UN 
PROJET DE RECHERCHE 
Titre du projet: "Niveau deforme physique et historique du dysfonctionnement de l'épaule 
chez des patients en attente d'une chirurgie du sein 
Vous êtes invité à participer à un projet de recherche qui sera menée par l'Université du 
Québec à Montréal et le Centre de bien-être de Ville Marie. Le chercheur principal est Alain-
Steve Comtois Ph.D., professeure agrégée, département de kinésiologie, l'Université du 
Québec à Montréal. L'équipe de recherche est composée de David H. Jones, étudiant au 
doctorat en biologie, l'Université du Québec à Montréa~ Melisa Nestore, kinésiologue, Ville 
Marie Wellness Centre (VMWC) et Sara Henophy, kinésiologue, VMWC. 
S'il vous plaît lire les informations ci-dessous et sentez vous entièrement libre de poser 
toutes les questions sur quoi que ce soit que vous ne comprenez pas avant de décider de 
participer ou non. Notez que la participation à l'étude est entièrement volontaire. 
BUT 
Je comprends que le projet de recherche vise à examiner la douleur de l'impact et des 
restrictions musculo-squelettiques, qui peuvent être présentes avant l'intervention 
chirurgicale, sur l'habilité à retrouver la mobilité de l'épaule après la chirurgie. 
PROCÉDURES 
Toutes les épreuves pour le projet se dérouleront au Centre de bien-être Ville Marie. Les tests 
se feront à deux reprises : avant la chirurgie et environ trois 3 semaines après la chirurgie. 
Résumé du protocole d'essai 
1. Je comprends que l'amplitude de mouvement, souplesse et force au niveau de mon 
épaule sera évaluée par un kinésiologue qui est membre de l'équipe de recherche. Des 
mouvements actifs seront effectués au meilleur de ma capacité sans aggraver une 
affection sous-jacente. Ma composition corporelle sera également évaluée en 
mesurant la circonférence au niveau de la hanche et de la taille. 
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2. Mon niveau de forme physique sera évalué en marchant sur un tapis roulant. Je 
devrai porter un moniteur de fréquence cardiaque pendant la marche à une vitesse 
prédéterminée sur le tapis roulant, jusqu'à ce que mon rythme cardiaque atteigne un 
seuil spécifié correspondant à mon âge. Cette fréquence cardiaque sera d'environ 80 
% de la fréquence cardiaque maximale prévue pour mon groupe d'âge. Ce test bien 
établi, connu comme le protocole de Bruce détermine monniveau de conditionnement 
physique sous-maximal. Je comprends quele test prendra environ 20 minutes à 
compléter. 
Aussi, il vous sera demandé ne pas de discuter de l'information recueillie durant ce 
test ou toute autre session de test afm de créer un biais chez les autres participantes 
durant le processus de collecte de données. 
3. L'étudiant de cycle supérieur mesurera mes seuils de pression/douleur à l'aide d'un 
algomètre. L'algomètre servira à mesurer la pression 1 au seuil de ma douleur. Un 
algomètre est un dispositif électronique servant à mesurer les variations de pression à 
la surface de la peau. L'algomètre a approximativement la même forme qu 'un 
scanner à barre mobile utilisé pour lire les codes à barres sur les items retrouvés dans 
les magasins. 
La sensation ressentie lorsqu'un algomètre est appliqué à la surface de la peau est 
semblable à une personne poussant son doigt dans son avant-bras. Au moment où la 
sensation sur la peau change de pression à la douleur, le test est arrêté au site de la 
mesure et les résultats sont enregistrés. Cette mesure est connue comme la pression 1 
seuil de douleur. 
On mesurera à l' aide de l'algomètre huit sites différents au niveau de votre cou, 
épaules et bras. Je comprends que les tests d'algomètre seront répétés 4 fois durant 
ma visite et cela dure environ 30 minutes pour compléter tous les 4 tests. 
4 . Je comprends que les séances d'examen préopératoire devraient prendre environ 1 ~ 
heures au total et que les tests post-chirurgie comprendront seulement la mobilité de 
l' épaule et les mesures avec l'algomètre, lee qui prendra environ 1 heure à compléter. 
ADMISSIBILITÉ 
Les participants sont les femmes âgées de 30 à 70 ans. Fernmesayant des antécédents 
d'hypersensibilité (fibromyalgie) ou hyposensibilité (manque de sensibilité) à la douleur 
seraient exclus de participer au projet. Toute les participantrs sont prévus pour une chirurgie 
mammaire. La chirurgie inclut une mastectomie partielle ou une mastectomie totale avec un 
échantillonnage de ganglion lymphatique. 
LES RISQUES POTENTIELS ET LES MALAISES 
Il est possible que je ressente une légère douleur à un ou plusieurs des points de repère/site 
après l'application de l' algomètre. Il est également possible que l'application de l'algomètre 
cause quelques ecchymoses locales. Pendant les essais physiques, il vous sera demandé 
d'effectuer la tâche jusqu'à ce que le niveau d'inconfort ne soit plus tolérable. 
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Après le test d'aptitude physique sur le tapis roulant, il se peut que je ressente de la fatigue et 
que je sois un peu plus fatigué que normalement. Cette fatigue devrait disparaître 15 - 20 
minutes après avoir complété le test. 
A V ANTAGES POTENTIELS 
De nombreux patients ont des limitations musculo-squelettiques après la chirurgie. Ces 
mêmes patients bénéficient souvent d'un programme de réadaptation structuré pour surmonter 
c'ertaines de ces limitations. Votre participation à ce projet aidera à identifier vos limitations 
musculo-squelettiques, le cas échéant et faciliter l'élaboration et la mise en œuvre d'un 
programme de réadaptation post-chirurgicale personnalisé. 
COMPENSATION POUR VOTRE PARTICIPATION 
Les participants qui terminent toutes les phases d'évaluation préopératoire et postopératoire 
pour ce projet recevront 2 séances de rééducation sans frais après leur chirurgie. La valeur 
totale de ces sessions est environ $150.00-$ 200.00. 
Les séances de rééducation seront effectuées par le thérapeute du sport qui est membre de 
l'équipe de recherche, mais aussi un clinicien avec le Centre de bien-être de Ville Marie. 
CONFIDENTIALITÉ 
L'information utilisée provient du dossier électronique et les données recueillies avec 
l'algomètre sont confidentielles. Seulement les membres du Comité d'éthique et de l'équipe 
de recherche auront accès aux données. 
Toutes les informations obtenues au cours de cette étude sont strictement confidentielles et ne 
seront pas révélées à quiconque sans le consentement de votre part. Toutefois, les 
renseignements recueillis peuvent être utilisés pour faire progresser l'ensemble des 
connaissances scientifiques et peuvent, donc, être publiés dans des revues scientifiques où 
l'anonymat de votre participation sera entièrement préservé. 
Certains des renseignements obtenus dans l'étude seront stockées dans la base de données 
électronique de Ville Marie. Ces informations incluent l'amplitude de mouvement au niveau 
de l'épaule, de la remise en forme du mouvement, votre poids et votre grandeur. Les 
renseignements obtenus par l'utilisation de l'lagomètre seront stockés dans classeur sécurisée 
et ordinateur dont l'accès est protégé par un mot de passe au département de kinésiologie de 
l'UQAM et ne seront pas stockées dans la base de données électronique à Ville-Marie. 
PARTICIPATION ET RETRAIT 
Ma participation à ce projet de recherche est strictement volontaire et je suislibre de me 
retirer à tout moment avant ou pendant les sessions expérimentales. Mon retrait de ce projet 
n'aura absolument aucun effet sur la qualité des soins que je recevrai au Centre médical Ville 
Marie. 
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APPROBATION DU PROJET DE RECHERCHE 
Ce projet de recherche a été approuvé par les comités d'éthique du Centre médical Ville 
Marie et le l'Université du Québec à Montréal (UQAM). Les coordonnées des comités 
éthiques sont indiquées à la fm du présent formulaire de consentement. 
QUESTIONS 
Vous êtes invité et entièrement libre de poser toutes questions que vous croyez pertinentes. 
Toute question concernant le projet, plaintes ou observations peut-être être adressée à l'un des 
chercheurs impliqués dans ce projet de recherche. En outre, les sujets sont invités à demander 
des explications supplémentaires s'ils ont des doutes quant à la participation au projet de 
recherche. Les chercheurs responsables du projet de recherche sont Alain-Steve Comtois, 
Chercheur Principalet David Jones, étudiant au doctorat en biologie. On trouvera leurs 
coordonnées à la fm du présent formulaire de consentement. 
Toutes questions concernant la responSabilité des chercheurs, ou dans l'éventualité d'une 
plainte ne peut pas être adressée directement aux enquêteurs, vous pouvez communiquer avec 
le représentant du Patient au Comité d'éthique de la Ville Marie Centre médical ou le sous-
comité de l'éthique de l'UQAM (Sous-comité du Comité Institutionnel d'Éthique de la 
Recherche chez l'Humain de l'UQAM) directement. Vous trouverez les coordonnées des 
Comités à la fm du présent formulaire de consentement. 
CONSENTEMENT 
Je suis satisfaite des explications que j'ai reçues et je conviens avoir entièrement lu et compris 
les procédures. Je suis consciente des risques encourus en participant à ce projet et qui sont 
décrits dans le présent formulaire de consentement. 
Je consens à être un sujet dans le projet de recherche intitulé " Niveau de forme physique et 
historique du dysfonctionnement de l'épaule chez des patients en attente d'une chirurgie 
du sein 
Date: 
------------------------
Name: ________________________ Signature: ______________________ __ 
(En lettres moulées) 
Témoin: ______________________ Signature: ________________________ __ 
(En lettres moulées) 
COORDONNÉES 
Alain-SteveComtois, Ph.D. 
Tél: (514) 987-3000 1083 local 
Courriel:comtois.alain-steve@ugam.ca 
David H. Jones M.Sc., CAT (C), CSCS 
Tél: (514) 848-2424 3318local 
Courriel: David.Jones@concordia.ca 
Sous-comité du Comité Institutionnel d'Éthique de la Recherche chez l'Humain 
Secrétariat du Comité - Service de la recherche et de la création 
Université du Québec à Montréal 
C.P. 8888, succursale centre-ville 
Montréal, QC H3 C 3 P 8 
Tél: (514) 987-3000 locale 7753 
Courrier électronique :SRC@UQAM.ca 
Sheila Mason,Représentante des patients 
Comité d'éthique, Clinique Médicale Ville-Marie 
1538 Sherbrooke St. Ouest lOe Étage 
Montréal, QC, H3G ILS 
Tél : (514)933-2778 
Courriel: info@villemariemed.com 
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Université du Québec à Montréal 
CtKTRE ~tf.I)JCAI. VII.LE·llfAR!t 
YU.t.\>1'-fio.Jt.U Mli.OH~c\L (::!:STIJl 
CONSENT FORM TO PARTICIPA TE IN A RESEARCH PROJECT 
Project tille: "Fitness level and history of shoulder dysfunction in patients preparing for 
breast sparing surgery" 
Y ou are being asked to participate in a joint research project to be conducted by l'Université du 
Québec à Montréal and the Ville Marie Wellness Centre. The principal investigator is Alain-
Steve Comtois Ph.D., Associate Professor, Department of Kinesiology, l'Université du Québec 
à Montréal. The research team is comprised of David H. Jones, Doctoral Student in Biology, 
l'Université du Québec à Montréa~ Melisa Nestore, Kinesiologist, Ville Marie Wellness Centre 
(VMWC), and Sara Henophy, Kinesiologist, VMWC. 
Please read the information below and ask questions about anything you do not understand 
before deciding whether or not to participate. Note that participation in the study is entirely 
voluntary. 
PURPOSE 
1 understand that the purpose of the research project is to examine the impact pain and 
musculoskeletal restrictions, which may be present before surgery, have on 
theparticipantregaining shoulder mobility after surgery. 
PROCEDURES 
Ali testing related to the project will be conducted at the Ville Marie Wellness Centre. Testing 
will be done on two different occasions: before surgery, and approximately three (3) weeks 
after surgery. 
Surnmary ofTesting Protocol 
1. 1 understand that my range of motion, flexibility and strength will be assessed by a 
kinesiologist who is a member of the research team. Active movements will be 
performed to the best of my ability without aggravating any underlying condition. My 
body composition will also be evaluated througb hip to waist circumference 
measurements. 
2. My fitness level will be assessed by walking on a treadmill. 1 will wear a heart rate 
monitor and will be required to walk at a predetermined speed until my heart rate 
reaches a specified level that corresponds to my age. This heart rate will be 
------------- ------
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approximatély 80% of the maximum capacity expected for my age group. This weil 
established test known as the Bruce Protocol will determine mysub-maximal fitness 
level. 1 understand thatthe testing will take approximately 20 minutes to complete. 
1 will be asked not to discuss any of the information that was collected at the fitness 
level testing session or any other session in order to avoid creating any bias with the 
data collection process. 
3. The graduate student will measure my pressure/pain thresholds using an algometer. An 
algometer will be used to measure my pressure/ pain threshold. An algometer is a 
band- held electronic deviee used to measure changes in pressure on the skin' s surface. 
The algometer is approximately the same shape as a mobile bar scanner used to read 
the bar codes on items in a department store. 
The sensation one feels when an algometer is applied to skin is similar to someone 
pushing their fmger into one's forearm. The moment that the sensation on the skin 
changes from pressure to pain, the test is stopped at that testing site and the results 
recorded. This measurement is k:nown as the pressure/ pain threshold. 
Eight different landmarks around my neck, shoulder and arm will be measured with the 
algometer. 1 understand that the algometer tests will be conducted 4 times and will take 
approximately 30 minutes to complete ali 4 tests. 
4. 1 understand that the pre-surgery testing sessions are expected to take approximately 1 
Yz hours in total and that the post-surgery testing, which will include only shoulder 
mobility testing and testing with the algometer, will take approximately 1 hour to 
complete. 
ELIGIBILITY 
Participants are females between the ages of 30 and 70 years of age. Womenwith a history 
of hypersensitivity (fibromyalgia) or hyposensitivity (lack of sensitivity) to pain would be 
excluded from participating in the project. Ail participants are scheduled for breast surgery. 
The surgery includes either a partial mastectomy or a full mastectomy with lymph node 
sampling. 
POTENTIAL RISKS AND DISCOMFORTS 
1 may experience mild pain at one or more of the landmarks following the application of the 
Algometer. It is also possible that the application of the algometer may cause sorne local 
bruising. During the physical tests, 1 will be asked to conduct the task until the level of 
discomfort is no longer tolerable. 
After the fitness test on the treadmill 1 may fee] tired and a bit more fatigued than 1 am 
normally. This tiredness and fatigue should disappear within 15 - 20 minutes after completing 
the test. 
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POTENTIAL BENEFITS 
Many patients have musculoskeletallimitations after surgery. These same patients often benefit 
from a structured rehabîlitation program to overcome sorne of these limitations. Participating 
in this project will help to identify the participant's musculoskeletal limitations, if any, and 
facilitate the development and implementation of a personalized post-surgical rehabilitation 
pro gram. 
COMPENSATION FOR PARTICIPATION 
Participants who complete all phases of the pre-surgery testing and post-surgery testing for this 
project will receive 2 rehabilitation sessions free of charge following their surgery. The total 
value ofthese sessions is approximately $150.00-$200.00. 
The rehabilitation sessions will be conducted by the Athletic Therapist who is a member of the 
research team as weil as a clinician with the Ville Marie Wellness Centre. 
CONFIDENTIALITY 
The information used from the electronic chart and the data obtained from the algometer is 
confidential except to the members of the ethics committee and Primary Investigator. 
AU the information obtained during the course of this study is strictly confidential and will not 
be released to anyone without the subject's written consent. However, the information collected 
may be used to advance the body of scientific knowledge and may, therefore, be published in 
scientific journals where the subject's anonymity will be entirely preserved. 
Sorne of the information obtained in the study will be stored in the Ville Marie electronic 
database. This information includes a participant' s height, weight, fitness lev el, and shoulder 
range of motion. Information obtained through the use of the algometer will be stored in a 
secure facility at UQAM and will not be stored in the electronic database at Ville Marie. 
PARTICIPATION AND WITHDRAWAL 
My participation in this research project is strictly voluntary and 1 amfree to withdraw at any 
time prior to or during the experimental sessions. Withdrawal from this project will have 
absolutely no effect on the quality of care 1 will receive while at the Ville Marie Medical 
Centre. 
RESEARCH PROJECT APPROV AL 
This research project bas been approved by the ethics committees of the Ville Marie Medical 
Centre and the l'Université du Québec à Montréal (UQAM). The ethics committees' 
co9rdinates may be found at the end of this consent form. 
QUESTIONS 
Participants are entirely free to ask any questions that they believe are relevant. Any question 
about the project, complaints, or comments may be addressed to any of the investigators 
involved in this research project. In addition, subjects are invited to ask for additional 
explanations if they have any doubts about participating in the research project. The 
investigators responsible for the research project are Alain-Steve Comtois, Principal 
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Investigatorand David Jones, M.Sc., CAT(C), CSCS. Their coordinates may be found at the 
end of this consent form. 
Questions regarding the responsibility of the investigators, or in the event that a complaint 
cannat be addressed directly to investigators, you may contact the Patient Representative at the 
Ville Marie Medical Centre ethics committee or the UQAM Ethics sub-committee (Sous-
comité du Comité Institutionnel d 'Éthique de la Recherche chez l 'Humain de /'UQAM) 
directly. The Committee's coordinates may be found at the end of this consent form. 
CONSENT 
I am satisfied with the explanations that I have received and have fully read and 
understand the procedures. I am aware of the risks involved in participating in this 
project, which have been outlined in this consent form. 
I consent to be a subject in the research project entitled "Fitness level and history of 
shoulder dysfunction in patients preparing for breast sparing surgery". 
Date: 
Name: 
-=~~~-------------(Please print) 
Witness: 
~--~---------------(Please print) 
COORDINATES 
Alain-Steve Comtois, Ph.D. 
Tel: (514) 987-3000 local1083 
E-mail:comtois.alain-steve@uqam.ca 
David H. Jones, M.Sc., CAT(C), CSCS 
Tel: (514) 848 2424 local3318 
E-mail: David.Jones@concordia.ca 
Signature: ___________________ _ 
Signature: ___________________ _ 
Sous-comité du Comité Institutionnel d'Éthique de la Recherche chez l'Humain 
Secrétariat du Comité - Service de la recherche et de la création 
Université du Québec à Montréal 
C.P. 8888, succursale centre-ville 
Montréal, QC H3C 3P8 
Tel: (514) 987-3000 locale 7753 
E-mail:src@uqam.ca 
Sheila Mason,Patient Representative 
Ethics Committee, Ville Marie Medical Centre 
153 8 Sherbrooke St. West 1 Oth Floor 
Montréal, QC, H3G 1L5 
Tel : (514)933-2778 
E-mail : info@villemariemed.com 
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ANNEXC 
MANUSCRIPT: ANTHROPOMETRie AND VITAL SIGN MEASUREMENTS OF 
CANCER SURVIVORS STRATIFIED ACCORDING TO TREATMENT 
This manuscript was presented as part of the research poster presentations at the 2013 
Annual American Co liege of Sports Medicine (ACSM) Conference. 
Abstract 
The Integrative Health and Wellness Center (WC) at the Ville-Marie Medical Centre 
(VM Medical) was established to monitor the body composition, physical activity 
leveL and vital signs ofregular (R) patients and cancer survivors (CS) as part oftheir 
annual mammography screening. 
Objective 
The objective of this study was to determine if body composition and basic 
cardiovascular function of CS vary depending on the type of adjuvant therapy received. 
Methods 
Kinesiologists performed baseline measurements on 4,414 female patients at VM 
Medical. Measurements were obtained on 3,674 R patients and 740 CS. The data 
included Body Mass Index (BMI), resting heart rate, blood pressure, total body fat, lean 
muscle and waist circurnference. The CS were stratified into eight different groups 
(Gl-G8) according to the surgery type (ST) they underwent and were compared with 
the R patients. A one-way ANOVA was performed with Dunnet's post hoc analysis. 
Significance was set at p < .05. The two largest CS groups were, Group 5 (G5) 
consisting of 243 women who underwent surgery, chemotherapy, radiotherapy and 
hormone therapy as part oftheir treatment and Group 6 (G6) consisting of207 women 
who underwent surgery, radiotherapy and hormone therapy as part of their treatment. 
The remaining 290 CS were classified into 6 treatment groups. 
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Results 
Signi:ficant differences were seen between the CS and R patients in ali groups with p= 
0.00 in 7 key variables. BMI (F=4.30) J.l= 26.08 (RP) vs J.l= 27.10 (G6), resting heart 
rate (F= 6.24) J.l= 73.04 bts/min (RP) vs J.l= 76.45 bts/min (G5), diastolic blood 
pressure (F= 4.65) J.l= 74.18 mmHg (R) vs J.l= 77.00 mmHg (G5), systolic blood 
pressure (F= 8.75) J.l= 123.04 mmHg (RP) vs J.l= 130.14 mmHg (G6), lean muscle (F= 
3.48) J.l= 10.09 kgs (RP) vs J.l= 9.74 kgs (G6), total body fat (F=9.02) J.t= 34.45% (R) vs 
J.l= 37.49 %(G6) and waist circumference (F= 4.44) J.l= 84.91 cm (RP) vs J.l= 87.68 cm 
(G5). 
Conclusion 
It would appear that different treatment protocols are associated with an increase in 
negative body composition and blood pressure measurements in cancer survivors (CS). 
This information is important for the medical team to consider when directing the CS 
on healthy lifestyle choices post treatrnent. 
Introduction 
Undergoing treatment for breast cancerisa very challenging event for many women as 
weil as their families and friends. Treatment, although necessary, may lead to 
unexpected changes in body composition (Carmichael and Bates, 2004) It is unclear 
how cancer therapy affects body composition and blood pressure of breast cancer 
survivors. Sorne studies have shown significant changes taking place while other 
studies indicate no significant changes taking place (Calle and Kaaks 2004). 
Women receive a signi:ficant amount of information re garding the appropriate treatrnent 
options available, which are dependent upon the recommendations made by the Tumor 
Board that evaluates and provides the stage category for the tumor that was removed. 
The women are advised about sorne of the temporary side effects that may take place as 
they undergo treatment as weil as the less apparent long-term side effects. The 
layperson's perception of the effects of cancer treatment may be different to what 
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actually occurs. Physicians may only focus on body weight to provide a glimpse as to 
what is happening with their patient (Franceschi and Wild 2013). Patients, with no 
previous experience with cancer treatment, may anticipate that they will lose weight 
and become emaciated whereas professionals working with patients throughout 
treatment often see patients' body weight increase over time. 
The goal of this study was to observe how different cancer treatment protocols affect 
body composition measures. Our researchers believe that as patients go through therapy 
there is an increased likelihood they would see changes in cardiovascular risk factors. 
This would include increase in blood pressure, resting heart rate values, increase in 
body fat, BMI, and waist circumference as well as a decrease in lean muscle mass. 
Methodology 
As part of the standard intake evaluation, patients waiting to meet with one of the 
physicians at VM Med underwent a series of tests administered by one of the 
kinesiologists working at the WC. Results from tests, which included vital signs and 
body composition measurements, were entered into the VM Med's electronic medical 
records. The information that was extracted from the electronic database and that was 
used for this study had persona! information removed so that no individual could be 
identified. Each patient that came to VM Med was asked to review and signa consent 
form that allowed for their medical information to be entered into the database. The 
database was used by the medical team to monitor and address patient needs. This 
study was approved by the VM Medical Ethics Board and conformed to the World 
Medical Association (WMA) Declaration of Helsinki, Ethical Principles for Medical 
Research lnvolving Human Subjects. 
As part of the preparation for testing, patients were asked to refrain from smoking or 
drinking caffeine products for 4 hours before testing. Before testing began, patients 
were also asked if they needed to use the washroom to void any fluids. Patient testing 
took place in a medical evaluation room, away from the main clinic area. The 
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kinesiologist explained to the patient the purpose for the testing. A:fter approximately 5 
minutes the patient was given the opportunity to relax and ask questions before the 
testing began. 
Resting heart rate and blood pressure values were obtained through the use of a 
Physiologie Auto-memory 90 instrument (AMG Medical Inc., Montréal Canada).The 
patient's left arm was used for testing. If the patient had breast surgery on the left side 
of their torso with lymph node(s) removed, the right arm was used. The cuff was 
wrapped around the upper armand was supported at the level of the heart. The cuffwas 
aligned with the brachial artery. If measurements obtained on the patient were outside 
of expected values for the patient's age group, the test was repeated after a 5-minute 
waiting period. The patient' s height and weight were measured using a stadiometer and 
weight scale respectively. 
The In-Body 230 (Seoul, Korea) impedence unit (Karelis et al 2013) was used to 
determine body weight, percent body fat, lean muscle mass, and total body water. The 
patient was asked to remove shoes and socks as well any external metal objects (e.g. 
watches, rings) which might affect the results. The patients then stood on the foot pads 
of the unit and held on to the external handles so that data could be recorded. The 
kinesiologist documented the data, which was displayed on the screen. 
Waist circurnferences were the final measurements taken. Utilizing the ACSM 
(American College of Sports Medicine 2013) measurements methodology were 
obtained at the level of the greater trochanter of the hip and the umbilicus using a 
Gulick anthropometrie tape (Mississagua, Ontario Canada). Waist measurements were 
performed with the patient standing upright, feet together, and arms at their side while 
maintaining a relaxed breathing pattern. A horizontal measure was taken at the 
narrowest location between the umbilicus and the sternum. The test was repeated two 
times and the average was taken. If there was a difference of more than 5 millimeters 
between measurements, a third measurement was taken. 
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For this study, patients were classified into two groups; cancer survivors (CS) or 
regular (R) patients. Ali of the women classified as CS underwent either a partial or a 
full mastectomy, and may have received adjuvant therapy such as chemotherapy, 
radiotherapy and hormonal therapy. Sorne patients may have received only one 
adjuvant therapy while other patients may have received up to three. Patients classified, 
as R patients may not have had any of the adjuvant therapies mentioned above. Both 
the CS and R patients may also have had other health issues for which they were taking 
additional medication that may have affected outcome measurements. 
CS were stratified according to the type oftreatment intervention they underwent. The 
eight different groups included: 1) Surgery only; 2) Surgery and chemotherapy; 3) 
Surgery and radiotherapy; 4) Surgery and hormone therapy; 5) Surgery, chemotherapy, 
radiotherapy and hormone therapy; 6) Surgery, radiotherapy and hormone therapy; 7) 
Surgery, chemotherapy and radiotherapy; and 8) Surgery, chemotherapy and hormone 
therapy. 
Data Analysis 
Statistical analyses were performed using IBM SPSS version 19.0.A one-way ANOVA 
was performed with Dunnett post-hoc analysis. Significance was calculated at P< 0.05. 
The R patients were used as the control group. Patients were also stratified according to 
age, in groups of 10 years. The same one-way ANOV A with Dunnett post-hoc analysis 
was performed. 
Results 
The mean age of the CS of the 8 different age categories (G l-G8) varied from 56-63 
years of age compared to a mean age of 55 years for the R patients The unilateral 
reconstruction category had a mean age of 56 years, which was closest to the R 
patients. 
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Diastolic blood pressure values were highest in G4 - Surgery and hormone therapy: 
(77.00 mmHg SD 10.42) and lowest in G2- Surgery and chemotherapy: (73 .85 mmHg 
SD 9.35). 
Systolic blood pressure values were highest in G4 - Surgery and hormone therapy: 
(130.42 mmHg SD 13.55) and G7 - Surgery, radiotherapy and hormone therapy: 
(130.20 mmHg SD 16.20) and lowest in the Rpatients (123.48 mmHg SD 15.83). 
Mean arterial pressure (MAP) values were highest in G6 - Surgery, radiotherapy and 
hormone therapy: (94.03 mmHg SD 10.55) and the 1owest in the R patients: (90.10 
mmHg SD 12.59). 
Resting heart rate values were highest in G7 - Surgery, chemotherapy and radiotherapy: 
(79.10 bpm SD 14.44) and lowest in G2 - Surgery and chemotherapy (70.23 bpm SD 
9.39). 
Body mass index (BMI) values were highest in G 1 - Surgery on1y (28.89 SD 6.60) and 
lowest in G3 - Surgery and radiotherapy: (26.02 SD 3.76) and the R patients (26.08 SD 
5.16) 
Mean muscle mass (MAP) values were highest in the R patients: (10.09 kg SD 1.38) 
and lowest in G3- Surgery and radiotherapy: (9.74 kg SD 1.04). 
Total body water valueswere highest in the R patients (27.69 kg SD 3.68) and lowest in 
G3- Surgery and radiotherapy: (26.35 ~g SD 4.48). 
Percent body fat values were highest in G 1 - Surgery only (39.12% SD 7.49) and 
lowest in the R patients (34.45% SD 8.27). 
Waist circurnference values were highest in G1- Surgery: (90.37cm SD 13.16) and the 
lowest in the R patients: (84.91 cm SD 11. 79). 
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Patients were also stratified by age. The 40-49 age groups and the 50-59 age group 
showed significant differences between their outcomes values compared with the R 
patients. 
Patients in groups Gl, G5, G6 and G7 were also stratified according to the surgery they 
underwent. The surgeries included partial mastectomy, full mastectomy, bilateral 
mastectomy, unilateral reconstruction and bilateral reconstruction. 
There was one woman in the 20-29 age group, 5 women in the 30-39 age group and 2 
women in the 80-89 age group. 
Discussion 
Our analysis shows that the body composition and blood pressure values in women 
undergoing treatment for breast cancer are affected by the type of treatment they 
receive. Patients who underwent only surgery and radiotherapy (G3) and surgery and 
chemotherapy (G2) appeared to have been affected the least, while patients who 
received multiple types of surgeries combined with two forms of adjuvant therapy 
(whether chemotherapy, radiotherapy or hormone therapy) seemed to be the most 
affected. Women who underwent surgery without any adjuvant therapy also had sorne 
of the poorest outcome measures. 
Surgery and hormone therapy appeared to affect blood pressure values and resting heart 
rate the most, while having minimal effect on body composition. Diastolic, systolic and 
MAP (mean arterial pressure) blood pressure values were the most elevated in groups 
Gl , G4, G5, G6, G7 and G8. With the exception of Gl, these groups had received 
hormone therapy or multiple forms of adjuvant therapy. 
Body fats and waist circumference values were the highest in groups G 1, G5, G6 and 
G7. It was expected that the women who had the most aggressive treatments would 
have the most significant differences in body composition in comparison to the R 
patients, who received no treatment. 
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Previous work by Botteri et al 2012 looked at the incidence of morbidity related to 
patients that did or did not have radiotherapy. There was speculation that radiotherapy, 
a necessary treatment for sorne patients depending on lymph node involvement and 
tumor size, may increase the risk of cardiomyopathy. We expected that the women who 
underwent surgery and radiotherapy would have poorer blood pressure and resting 
heart rate values than other groups. Only when radiotherapy was combined with other 
treatments were the measures poorer, which was seen in groups G5, G6 and G7. The 
G3 group had blood pressure and resting heart values that were similar to the R 
patients. We did not know which breast the women underwent treatment for. There 
was speculation that treatment on the le:ft side would have a more adverse effect on the 
cardiovascular markers. It is also possible that with improvement in radiotherapy 
techniques the negative effects on the heart have been diminished. Our analysis of this 
data may have been different if we had had access to more detailed information on the 
patient such as tumor size and node involvement and how far removed the patients 
were from treatment. 
Age-matched analysis was done for the different treatment groups. Looking at age 
groups 40-49, 50-59 and 60-69, the same trends were seen with body fat and waist 
circumference as weil as blood pressure values, with G 1, G5 and G6 having sorne of 
the poorest outcome measures. 
The 40-49 age group seemed to have been affected the most by treatrnent. Even though 
we see the same trends in the 50-59 and 60-69 age groups, it would appear that 
treatment had a greater impact on the younger group. Previous work by Sheean and 
colleagues noted that there was an increase in psychological and social stress associated 
with this group (Sheean, Hoskins and Stolley 2012) and it would also appear that 
physiological stress could be added to this list. The increase in stress was believed to be 
related to the increased demands of farnily and work for this age group. 
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It is unclear why patients who orùy underwent surgery seemed to have had sorne of the 
poorest outcome measures. It was expected that this group would have the outcome 
measures closest to the R patients, since they would have had the least amount of 
treatment. It is possible that for patients in this group surgery was the orùy 
recommendation that was made by the Tumor Board. Often at least one form of 
additional treatment is recommended to the patients. It is also possible that sorne ofthe 
women in the study decided not to take any other additional adjuvant treatment. The 
women may not have received any additional information/direction regarding the 
possibility of reoccurrence of their breast cancer nor about the possibility of 
cardiovascular risk. Futhermore perhaps these women based their decisions on 
treatment that did not include sorne of the standard medical approaches. With the 
surgery alone group (G1), it would be important to gain a better understanding ofwhy 
they had such poor outcome measures. They may not have received direction from the 
medical team as to the type of activity they could have undertaken to reduce their risk 
factors. It is also possible that they were a:fraid to precipitate a reoccurrence and 
decided not to pursue any further treatment. 
The surgery alone group (G1) was stratified according to the type of surgery that was 
performed to see if there was any relationship between the type of surgery and the 
poorer outcome measures. Blood pressure values and resting heart values were elevated 
for women receiving a partial mastectomy and unilateral reconstruction. Body 
composition across ali surgical groups, in particular body fat and waist circurnference, 
were significantly different when compared to R patients. 
Over the past two decades we have seen significant changes in our society with regular 
physical activity becoming a smaller part of people's lifestyle (Blair et al 2012, Flegal 
et al 2010). A number of women enjoy participating in prograrns such as yoga to 
improve flexibility and reduce levels of stress. Undergoing cancer treatment can be 
very stressful. Unfortunately, yoga has limited effects on body composition and 
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cardiovascular conditioning. This would be another area which should be further 
evaluated (Hojan et al2012). 
It would have been useful to k:now what the pre-intervention body composition and 
blood pressure values of the women when were conducting our analyses; however, this 
information was not available to us. With long term monitoring of the women at the 
WC perhaps this information could be made available in the future. It would important 
to k:now how long it would tak:e for the women' s outcome measures to return to the 
same levels as the women in the R patient group. 
Sorne of the limitations of this study include not k:nowing the dates of the surgery or the 
treatment, the turner size or its location, how many lymph no des, if any, were removed 
and whether or not any of the nodes tested positive. Alos, it would have been useful to 
t k:now the estrogen receptor status of the patient at the onset oftreatmentas weil as the 
type of treatment the patient underwent pertaining to chemotherapy or hormonal 
therapy. Ail of the above factors would be confounding variables to the data that has 
been collected. 
Patients undergoing cancer treatment can expect to undergo significant changes in body 
composition and blood pressure values in comparison to patients of the same age not 
undergoing treatment. It is unclear from our data when these changes tak:e place in the 
women. Is it when they are undergoing the different treatment protocols or is it after 
they have completed their treatment? It is also unclear whether or not the changes in 
blood pressure and body composition values occur over an extended period of time or 
if they are short term in nature. A review of the literature appears to indicate that these 
changes occur during treatment (Demark-Wahne:fried et al2001 , Nissen, Shapiro and 
Swenson 2011). Once the women gain the additional weight it would appear that the 
added weight stays with them over time. As people age, blood pressure values tend to 
go up and body composition values tend to become larger (American Co liege of Sports 
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Medicine (ACSM) 2008). It is possible that the R patients eventually catch up to the CS 
as our collected data shows acceleration in values with aging. 
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